Analysis and parametrisation of an IBM of a Leishmania infantum in vitro culture by Goonesekera, Estelle Maria
 
Analysis and parametrisation of an IBM of a Leishmania infantum in vitro culture  1 
 
Abstract 
 
Leishmaniasis is a vector borne protozoan parasitic disease with the ninth highest burden 
amongst infectious diseases. There is a pressing need for the development of novel, improved 
drugs for its treatment. Currently, the knowledge of the mechanisms of action of the parasite 
and the drugs that treat it is still limited. As a consequence, drug research begins with in vitro 
screening. This makes an increase in the understanding of Leishmania infected macrophage 
cultures necessary for the improvement of drug screening methods. 
Aim: 
The purpose of this work is to parametrise an individual based model (IBM) of a Leishmania 
infantum and murine cell line RAW 264.7 in vitro culture. This process consists of the comparison 
of experimental results and the simulation outcome of the IBM. It is a necessary process in order 
to adjust the parameters of the model so that it gives the closest representation of the real 
system. On the one hand, this serves to shed light on the behaviour of this particular culture. On 
the other hand, the work proposes a mathematical methodology for parametrisation that is 
extensible to other cultures (different strains, cell lines, parasite species and medium 
composition). 
Experimental methods: 
The experimental design used to obtain the experimental data for the parametrisation of the 
model is described. The percentage of infected macrophages and the number of parasites per 
cell was determined at several time-points after infection. 
Parametrisation: 
The mathematical methodology for parametrisation is described and applied to this particular 
model. A preliminary analysis of the model was carried out in order to determine, for each 
parameter, the interval of values where simulation outcome and experimental results were 
most similar. The combination of these intervals, the parameter space, was then sampled using 
the Latin Hypercube Sampling (LHS) technique. Finally, the sampled combinations were 
implemented in the model and the outcome analysed. 
Results: 
On the one hand, a mathematical methodology for the parametrisation process was developed, 
extensible to different cultures. One the other hand, the combination that best reproduces the 
experimental results was determined. 
Conclusion: 
The development of the IBM has the potential to increase our understanding of the system and, 
therefore, lead to a more accurate approach in understanding and evaluating drug assays. 
However, the model still requires further expansion. In spite of the satisfactory results, there 
are still some improvements to be made to the parametrisation methodology. 
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Resum 
 
La leishmaniosi és una malaltia parasitària provocada per un protozou transmès per un vector. 
La seva incidència la situa com la novena malaltia infecciosa a nivell mundial. La necessitat de 
desenvolupar fàrmacs nous i millors és imperiosa. Actualment, encara, els coneixements sobre 
el mecanisme d’acció del paràsit i dels fàrmacs són limitats. Com a conseqüència, la recerca de 
nous fàrmacs s’inicia amb assajos in vitro. Això fa imprescindible per a la millora dels mètodes 
de triatge de fàrmacs una millor comprensió dels cultius de macròfags infectats per Leishmania. 
Objectiu: 
El propòsit d’aquest treball és parametritzar un model basat en l’individu (IBM) del cultiu in vitro 
de Leishmania infantum i la línia cel·lular murina RAW 264.7. Aquest procés implica la 
comparació de resultats experimentals amb les sortides del simulador i és necessari per a ajustar 
els paràmetres del model de manera que aquest representi amb màxima fidelitat el sistema real. 
Per una banda, serveix per a incrementar la comprensió del comportament d’aquest cultiu en 
particular. Per altra banda, el treball proposa una metodologia matemàtica per a la 
parametrització que pretén ser extensible a altres cultius (diferents soques, línies cel·lulars, 
espècies i composicions del medi). 
Mètode experimental: 
Es descriu el mètode experimental emprat per a obtenir les dades utilitzades per a la 
parametrització. Es determinen a diferents instants de temps el percentatge de macròfags 
infectats i el nombre de paràsits per cèl·lula. 
Parametrització: 
Es desenvolupa una metodologia matemàtica per a la parametrització i s’aplica a aquest model 
en particular. Un anàlisi preliminar permet establir en quins rangs de valors dels paràmetres la 
sortida del simulador s’assembla més a les dades experimentals. El conjunt d’aquests intervals, 
l’espai de paràmetres, és mostrejat amb la tècnica Latin Hypercube Sampling (LHS). Finalment, 
les combinacions de paràmetres mostrejades són implementades en el model i s’analitza el 
resultat. 
Resultats: 
Per una banda, s’ha desenvolupat una metodologia matemàtica per al procés de parametrització 
que és extensible a diferents cultius. Per altra banda, s’ha determinat la combinació de 
paràmetres mostrejats que millor reprodueix els resultats experimentals. 
Conclusions: 
El desenvolupament d’una metodologia per parametritzar models basats en l’individu té el 
potencial d’incrementar la nostra comprensió del sistema i, per tant, portarà a un enfocament 
més apropiat per a la comprensió i avaluació dels assajos de fàrmacs. Malgrat els bons resultats 
es constata que es poden realitzar, encara, algunes millores en la metodologia de 
parametrització. 
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Resumen 
 
La Leishmaniasis es una enfermedad parasitaria provocada por un protozoo transmitido por un 
vector. Su incidencia la sitúa como la novena enfermedad infecciosa a nivel mundial. La 
necesidad de desarrollar fármacos nuevos y mejores es imperante. Actualmente, los 
conocimientos sobre el mecanismo de acción del parásito y los fármacos son aún limitados. 
Como consecuencia, la investigación de nuevos fármacos empieza con ensayos in vitro. Es 
necesaria para la mejora de los métodos de elección de fármacos una mejor comprensión de los 
cultivos de macrófagos infectados por Leishmania. 
Objetivo: 
El propósito de este trabajo es parametrizar un modelo basa en el individuo (IBM) del cultivo in 
vitro de Leishmania infantum y la línea celular murina RAW 264.7. Este proceso implica la 
comparación de resultados experimentales con las salidas del simulador y es necesario para 
ajustar los parámetros del modelo de manera que este represente con máxima fidelidad el 
sistema real. Por un lado, sirve para incrementar la compresión del comportamiento de este 
cultivo en particular. Por otro lado, el trabajo propone una metodología matemática para la 
parametrización que pretende ser extensible a otros cultivos (diferentes cepas, líneas celulares, 
especies y composiciones del medio). 
Método experimental: 
Se describe el método experimental utilizado para obtener los datos usados para la 
parametrización. Se determinan a diferentes instantes de tiempo el porcentaje de macrófagos 
infectados y el número de parásitos por célula. 
Parametrización: 
Se desarrolla una metodología matemática para la parametrización y se aplica a este modelo en 
particular. Un análisis preliminar permite establecer en qué rangos de los valores de los 
parámetros la salida del simulador es más parecida a los datos experimentales. El conjunto de 
estos intervalos, el espacio de parámetros, se muestrea con la técnica Latin Hypercube Sampling 
(LHS). Finalmente, las combinaciones de parámetros muestreados son implementados en el 
modelo y su resultado es analizado. 
Resultados: 
Por un lado, se ha desarrollado una metodología matemática para el proceso de parametrización 
que es extensible a diferentes cultivos. Por otro lado, se ha determinado la combinación de 
parámetros muestreados que mejor reproduce los resultados experimentales. 
Conclusiones: 
El desarrollo de un IBM tiene el potencial de incrementar nuestra comprensión del sistema y, 
por tanto, llevará a un enfoque más apropiado para la comprensión y evaluación de los ensayos 
de fármacos. Sin embargo, el modelo requiere expansión. A pesar de los buenos resultados, se 
constata que se pueden realizar mejoras en la metodología de parametrización. 
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1. Introduction 
1.1. Neglected tropical diseases 
The term neglected tropical diseases (NTD) refers to seventeen diseases caused by parasites or 
bacteria that are prevalent in tropical and subtropical conditions (WHO 2017), as shown in Figure 
1. The relationship between these illnesses is not biological, it lies in the fact that they have been 
mostly eradicated in the most developed parts of the world and persist only in the poorest and 
most marginalised communities and in areas of conflict (CDC 2011). NTDs affect more than a 
billion people in more than 149 territories. All low-income countries1 are affected by at least five 
NTDs simultaneously. It is estimated that, every year, these diseases are responsible for 57 
million DALYs2 . It is also estimated that mass drug administration  for most these diseases has 
a cost of less than 50 dollar cents per person and year (CDC 2011). 
There exists a mutual dependence between neglected tropical diseases and poverty. The first 
would not be present on the scale that they are if the quality of life of those who suffer them 
was better and, in turn, the illnesses trap those who suffer them in the cycle of poverty. The 
diseases do not only affect people’s short term health and wellbeing, they also influence physical 
and cognitive development, entail a social stigma that can lead to discrimination (especially in 
women and girls) and limit productivity, further worsening the state of poverty (CDC 2011). 
Neglected tropical diseases are responsible for massive suffering and can lead to permanent 
disability and even death. Despite this, as the term neglected implies, they have scarce visibility 
and are far from being prioritised due to them almost exclusively affecting vulnerable 
communities without political representation. These communities generally live in rural areas 
or in suburbs in countries of the global South (WHO 2017). 
Those communities most affected by NTDs are those that live in close proximity to vectors and 
domestic animals (WHO 2017). Many NTDs are vector borne diseases. In epidemiology, a disease 
vector is any agent (living or inert) that transmits a pathogen to an organism. The role of animal 
reservoirs is also important. A reservoir is any agent or substance that harbours an infectious 
agent while suffering neither its symptoms nor effects. Reservoirs act as a source of infection 
for other organisms. Many domestic animals act as reservoirs for NTDs and other vector borne 
diseases. 
The World Health Organisation (WHO) proposes various strategies to combat these diseases: 
large-scale preventive treatments, more intensive management of cases in primary attention 
centres and vector control. It also includes general prevention methods such as access to safe 
drinking water and adequate sanitation and hygiene (WHO 2017). 
                                                          
1 According to the Word Bank, a country is considered of low income if the national income per capita is 
inferior to 1005 $ per year. 
2 DALYs or disability adjusted life years are a measure of overall disease burden, expressed as the 
number of years lost due to ill-health, disability or early death. It was developed in the 1990s as a way of 
comparing the overall health and life expectancy of different countries. 
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Figure 1. Global distribution of neglected tropical diseases (Mackey et al. 2014). 
 
1.2. Leishmaniasis 
Leishmaniasis, a notorious member of the NTDs, is a vector borne disease that may be caused 
by twenty species of the Leishmania genus, members of the protozoan Trypanosoma family. The 
parasites develop part of their cycle in humans and part in sand flies, which persists in warm and 
humid climates. This includes thirty species of mostly nocturnal phlebotomids with Phlebotomus 
being the most common in the Old World (Europe, Asia and Africa) and Lutzomyia in the New 
World (the Americas). The cycle of the parasite is shown in Figure 2. The parasite infects 
macrophagic cells of the mononuclear phagocytic system (skin, bone marrow, liver, spleen and 
lymphatic nodes).  
 
Figure 2. Lifecycle of Leishmania (CDC 2011). 
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The parasite has two distinct forms with physiological, biochemical and molecular differences. 
The extracellular form, known as promastigote (Figure 3A), is the one found in the digestive tract 
of the vector. It is mobile and has a flagellum. The intracellular form, known as amastigote 
(Figure 3B), is the one found in infected phagocytes. It is not mobile, has no flagellum and is 
much more virulent. 
A 
 
B 
 
Figure 3. (A) Promastigote (extracellular) and (B) amastigote (intracellular) forms of Leishmania (Samant et al. 
2018). 
There are three forms of the illness, depending on the symptoms: cutaneous, mucocutaneous 
and visceral. The cutaneous form entails skin ulcers, the mucocutaneous form entails ulcers at 
the nose, mouth and other mucosal tissues and visceral Leishmaniasis not only entails ulcers, 
but fever, a decrease in red blood cells and inflammation of the spleen and liver. The cutaneous 
form is the most common and is not fatal but can lead to severe scarring. The visceral form is 
the most severe and can lead to death if left untreated. Its progression depends on the efficacy 
of the immune system and the virulence of the parasite. It may even become chronic. 
1.2.1. Epidemiology 
It is estimated that 4 – 12 million people in 98 countries are affected by Leishmaniasis, 200 
million people live where the illness is common and it causes 20 – 50 thousand deaths a year 
(WHO 2017). Belonging to the group of neglected tropical diseases, its risk factors include: 
poverty, malnutrition, deforestation, lack of waste management and sanitation, lack of 
urbanisation and a depressed immune system. Leishmaniasis accounts for 2357000 DALYs 
(Hotez et al. 2004). 
Control measures to avoid the spread of Leishmaniasis include investment in case finding and 
treatment, vector control with residual insecticide house spraying, insecticide impregnated nets 
for beds and animal reservoir control (WHO 2017). For now, sand flies are still very sensitive to 
insecticides (Desjeux 1996), but there is a risk of them developing resistances in the future. 
1.2.2. Leishmaniasis and poverty 
Leishmaniasis is generally considered to be one of the most neglected diseases. There is a link 
between poverty of sufferers and the consequent failure of a free market pharmaceuticals to 
address them (Yamey & Torreele 2002). 
Poverty is associated with risk increasing factors such has poor housing, lack of sanitation and 
deficient waste management, coupled with a significant number of untreated patients and 
domestic animals. Poverty also increases the progression, morbidity and mortality of the 
disease. This is due to poor nutrition in combination with poor access to health care and the high 
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cost the process of prevention and treatment, from mosquito nets, to transport and the 
treatment itself (Alvar et al. 2006). 
The issue can also be looked at from a gender perspective. Women suffer more stigma than men 
and, therefore, suffer more barriers when it comes to healthcare. For example, a woman may 
need a male relative to accompany her to receive treatment. Less access to healthcare and 
treatment mean that women bare a higher disease burden than men. 
Poverty and Leishmaniasis create a mutually perpetuating cycle: poverty increases the likelihood 
of contracting the disease and makes it take a higher toll on the system. At the same time, the 
high cost of treatment and the loss of household income due to the inability to work or having 
to accompany a relative have long term consequences on the family economy. Basically, the 
disease increases poverty (Alvar et al. 2006). 
Like all NTDs, Leishmaniasis is largely ignored due to the fact that the people that suffer it have 
neither voice nor power to influence decision making. This is especially significant because public 
investment is urgently needed to break the vicious cycle of disease and poverty. On the one 
hand, to improve the general quality of life of people and, on the other hand, to promote active 
detection and early treatment, as well as other control measures (Desjeux 1996). 
1.3. Treatment of Leishmaniasis 
1.3.1. Current status 
There have been drugs to treat leishmaniosis since the 1960s and the most commonly used are 
pentavalent antimonials, amphotericin B and miltefosine. However, these are highly inadequate 
due to moderate to high toxicity, prohibitive costs and emergence of resistance (Berman et al. 
1989). All are administered parenterally except miltefosine, which is not adequate for children 
nor pregnant women. Leishmaniasis has been called a major health problem with no satisfactory 
treatment so far (Mishra et al. 2007). There is a clear need for safe, potent, oral, affordable and 
effective drugs to treat the different forms of the illness. 
1.3.2. Drug discovery 
The effort in drug discovery for human Leishmaniasis is limited due to the poor economic returns 
related to the fact that the disease affects mostly impoverished endemic areas (Nagle et al. 
2014). Organisations leading the research into drugs for Leishmaniasis treatment are the Drugs 
for Neglected Diseases initiative (DNDi), Genomics Institute of the Novartis Research Foundation 
(GNF) and the University of Dundee. 
Currently, there are few lead compounds, possibly due to technological hurdles and/or lack of 
resources. A lead compound is a chemical entity that has pharmacological or biological activity 
and could potentially be developed into a drug. Nevertheless, its structure needs to be optimised 
in order to better fit its target, thereby maximizing its beneficial effects and minimizing side 
effects. 
The compounds to be screened as possible leads against different diseases are stored in 
libraries. These are large collections of functionally diverse molecules that are used for the 
discovery of chemical matter active against a wide variety of targets and for phenotypic 
screening. The main challenges regarding the identification of novel leads are the difficulty of 
accessing high quality hits from screening libraries and a lack of a standardised screening 
cascade for the various stages of discovery and development (Bhuniya et al. 2015). All things 
considered, high throughput phenotypic screening essays offer a powerful tool for the discovery 
of therapeutically relevant leads for drug discovery (Moffat et al. 2017). 
Analysis and parametrisation of an IBM of a Leishmania infantum in vitro culture  13 
 
Drug discovery efforts can be based on targets or on phenotypic assays. The first are hypothesis-
driven molecular approaches where mechanistic details necessary for their implementation are 
not always available. The latter consist of evaluating the drug against the observable 
characteristics of the organism, for example, its ability to survive. 
Early in the progression of drug discovery, knowledge is acquired by empirical analysis. It serves 
to identify substances with therapeutic potential and their mechanism of action. However, even 
if this approach does not require understanding of the mechanism of action, it does require 
understanding of the biology enough to assess the effect of the therapeutic substance. Some 
notion of the dose-response relationship is necessary to further develop the substance as a drug 
(Swinney 2013). 
Phenotypic assays, previously non-existent due to complexity of cultures and lack of resources, 
have relatively recently been made possible by advances in technology. For diseases where 
many of the molecular mechanisms are unknown, phenotypic assays have been more successful 
than target-based efforts in identifying potential drugs. They have also been useful for 
understanding the biology of largely unknown illnesses, identifying possible targets and agents 
acting on previously unknown targets (Swinney 2013; Nagle et al. 2014). 
Once a lead has been identified, subsequent assays are performed in order to determine its 
suitability as a therapeutic agent. These include a mammalian cytotoxicity test, in order to 
discern between inhibitory activity of interest and general cytotoxicity. This is followed by a 
microsomal stability test to determine the effect of oxidative metabolism on the compound. 
Finally, an in vivo efficacy test is run in a murine model. It is important to screen appropriately 
in order to avoid non-specific effects.   
In the case of Leishmaniasis, due to the various disadvantages of parenteral administration, 
there is a pressing need for oral drugs that can be administered to the general population 
(miltefosine is inadequate for pregnant women and children). Therefore, oral bioavailability is a 
trait being pursued in lead development (Ortiz et al. 2017).  
Figure 4 shows the timeline of the drug development process, from the initial screening process 
until the final product is obtained. Notice how from thousands of compounds screened in the 
early stages, only one or two (approximately) are deemed suitable for administration. Note also 
that the period covers 11 to 15 years. This highlights the need to speed up initial screening in 
order to shorten the time needed to develop a drug, as well as to optimise resources. 
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Figure 4. Drug development timeline, from initial screening to the obtaining of the final product. 
Figure 5 shows a timeline of antileishmanial drug discovery, clearly showing its slow pace 
(Samant et al. 2018). Some of the most commonly used drugs (pentavalent antimonials and 
amphotericin B) have been used since the mid twentieth century. The gap between 
amphotericin B and miltefosine is more than forty years. It is also important to note that all of 
these drugs have major side effects and are far from ideal. 
 
Figure 5. Timeline of antileishmanial drug discoveries from the early 1920s to 2017 (Samant et al. 2018). 
The current trend in drug discovery for Leishmaniasis is drug repurposing, i.e., testing the 
leishmanicidal activity of drugs used to treat other diseases. For example, miltefosine is 
traditionally used as an anti-cancer drug. This approach offers a shorter and faster path towards 
drug identification and lowers the cost of development. 
1.3.3. Phenotypic assays 
In vitro cultures are commonly used for the preliminary screening of potential drugs. This 
technique requires less volume of substances, has a higher throughput and speed, lower cost 
and allows the reduction of the number of animals used in subsequent in vivo essays. However, 
it inevitably ignores important host factors such as absorption, immune response, etc. Ideally, 
in vitro cultures should contain an active (dividing) population of the mammalian stage of the 
parasite, have an easily quantified measure of drug activity and accurately show the activity of 
standard drugs at  the approximate concentration achieved in tissues (Croft 1986). 
High throughput screening (HTS) assays are implemented using an in vitro Leishmania culture. 
Usually, a single concentration of each substance is tested. It is validated by including a test for 
standard drugs. It has the potential of screening many compounds at once: many cultures are 
incubated in parallel, each in the presence of a potential lead compound. If correctly validated, 
can account for a high level of automation (Siqueira-Neto et al. 2010).  
The techniques used for the quantification of drug activity are very diverse. There are three 
forms of culture to be used in this type of essay: promastigotes, axenic amastigotes and 
Analysis and parametrisation of an IBM of a Leishmania infantum in vitro culture  15 
 
intracellular amastigotes (Figure 6A, 6B and 6C, respectively). Because of the importance of 
culturing the appropriate parasite form under relevant physiological conditions (Nagle et al. 
2014), there is an ongoing debate on the validity of especially promastigote and axenic 
amastigote essays, which will be subsequently described in detail. Differences in results 
between the three cultures have been widely reported. 
A 
 
B 
 
C 
 
Figure 6. (A) Promastigote assay, (B) axenic amastigote assay and (C) intracellular assay (Yau et al. 2010; 
Aulner et al. 2013). 
The promastigote culture consists of screening the drug against free promastigotes, without any 
mammalian cells, i.e., without infection. They are mostly used because they are easy to culture 
and of low cost, allowing a high screening throughput (Sharlow et al. 2009). It was observed by 
Carrió et al. (2000) that culture conditions affected the value of IC503. The main issue related to 
this type of culture is the high discrepancy found between its results and those of intracellular 
and in vivo assays (Callahan et al. 1997; Ephros et al. 1997), which is said to be related to the 
fact that the promastigote form is the one found in the insect vector and is therefore not 
relevant to the disease in mammals. 
                                                          
3 Concentration of an inhibitory substance capable of producing 50% of the maximum inhibition possible 
in vitro.  
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Axenic amastigotes are more similar to the disease relevant parasite stage (Sereno et al. 2000), 
but they are cultured alone, not inside cells as they are found in mammals. This entails certain 
differences in protein expression and drug susceptibility (Nagle et al. 2014) with a consequent 
high false positive rate (De Rycker et al. 2013). It is used because it too permits a high screening 
throughput. 
The intracellular amastigote assay is the most physiologically relevant, as it not only detects drug 
susceptibility but also host-cell dependent mechanisms. It is the most suitable of the three, even 
though it offers the lowest throughput due to its higher complexity and cost (Siqueira-Neto et 
al. 2010; Nagle et al. 2014; Nühs et al. 2015). It allows the elimination of compounds that do not 
affect amastigotes and also identifies those not effective on promastigotes that are effective on 
amastigotes. 
Sensitivity of Leishmania to drugs depends on species (Nelson et al. 1979; Avila & Casanova 
1982; Rangel et al. 1996; Carrió et al. 2000). This difference has been proposed to be due to 
differences in biochemical composition related to membrane sterol and lipid content (Goad et 
al. 1984; Beach et al. 1988; Beach et al. 1979). 
Sensitivity also depends on lifecycle stage, in many cases being higher in promastigotes than in 
intracellular amastigotes. This could be due to stage-specific activity reflected in differences in 
physiology, such as differences in biochemical composition of the membrane (Bouazizi-Ben 
Messaoud et al. 2017). It could also be due to differences in division rate and metabolism or due 
to more or less exposure, depending on their extracellular or intracellular state (Moreira et al. 
1998; Carrió et al. 2000; Escobar et al. 2002). The preparation of the culture and the compound 
have also been found to affect susceptibility (Ephros et al. 1997; Roberts et al. 1998). Berman et 
al. (1989) found that promastigotes and amastigotes have similar susceptibilities in the same 
environment, but it is clear that they do not exist in similar environments. 
Even though in many cases the effect of drugs is higher on promastigotes than on amastigotes, 
there are certain cases when the inverse situation is found. This has been attributed to active 
concentration of drugs in the macrophage phagolysosome or parasite vacuole. This 
phenomenon has been observed, for instance, for antimony derivatives. It has also been 
attributed to metabolization of the drug inside the macrophage to a form with higher 
leishmanicidal activity and to intrinsic susceptibility of the intracellular stage to the drug in 
particular (Berman et al. 1987; Callahan et al. 1997; Ephros et al. 1997; Roberts et al. 1998). It 
has also been found that medium composition may modify promastigote susceptibility (Peixoto 
& Beverley 1987). 
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1.4. Individual based models 
The aim of mathematical modelling is to find, interpret and validate approximate 
representations of systems. These are defined by concepts, elements and interactions that are 
described by means of mathematical objects and operations (Gomes Neves & Duarte Teodoro 
2010). The main requirement of a model is that its results have to be consistent with 
experimental data (Feynman & Bosch 1967). Models should be coherent and have descriptive 
and predictive capacity. They are always simplifications, but they capture the essence of the 
system enough to address specific questions (Grimm & Railsback 2005). 
There are two main strategies when it comes to modelling: top down and bottom up. If we are 
dealing with the modelling of a microbial community, the first describes the system at a 
population level and infers the behaviour of the individual from the macroscopic patterns. In the 
second, the behaviour of the system is described by establishing rules for the behaviour of the 
individuals and their interactions. Following these strategies, models can be classified into 
population and individual based models, respectively. The first, usually formalized by means of 
continuous equations, are more tractable, interpretable and understandable, but they can 
handle only a limited amount of complexity. Individual-Based Models (IBMs) can handle almost 
an unlimited amount of complexity, but are more difficult to develop, understand and explain. 
Neither type of model is entirely superior, all approaches are needed to maximize 
understanding. As is said in Peck (2004), “the world is complex and we need all the tools we can 
muster to understand it”. 
Individual based models are those simulation models that treat individual as discrete and unique 
entities that have at least one property, apart from age, that changes during their life cycle 
(Grimm 1999). The behaviour of the individuals is governed by a set of rules (equations) and the 
overall behaviour of the system is a consequence of the interaction between individuals. This 
permits them to explore the relationship between the low level interactions of individuals and 
the macroscopic patterns that emerge from them (Ginovart et al. 2011). 
In fact, an interesting aspect if IBMs are emergent behaviours at the population level, which are 
not evident nor self-contained, but that are observed none the less as a consequence of the 
behavioural patterns of the individuals (Grimm 1999). This kind of model aims to trace back the 
system’s properties to the behaviour of the individuals, explaining the system’s properties as a 
consequence of the properties of the single individuals (Kaiser 1979). 
IBMs incorporate stochasticity at an individual level, in order to model individual variability. 
However, the macroscopic behaviour is deterministic: predictions can be made. There is an 
exception to this behaviour when working with few initial individuals, where, due to 
deterministic chaos, the macroscopic pattern is unpredictable. Together with the bottom up 
strategy, individual variability gives more realism to the model (Ferrer et al. 2008). The structure 
of IBMs also allows the integration of observations directly into the model without having to 
rewrite a whole set of equations (Grimm 1999).  
This type of model is not easily constructed and is difficult to understand and analyse. Neither 
is the relevance of input information always clear. The necessary data at individual level is often 
difficult to obtain from experimental data, although individual observation techniques have 
improved in recent years. With these new technologies, traits and activities at an individual level 
can be observed and measured, for example, individually differing phenotypes in a microbial 
population. By combining this data with IBMs, the emergent population behaviour can be 
modelled. 
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Because the available data for the characterisation of individuals is not always available, a 
parametrisation process is always necessary. It consists of adjusting the parameters of a model 
in a way that the simulation outcome replicates the experimental results as closely as possible. 
This process often involves large numbers of parameters, making it very complex. There is often 
a range of values of a parameter where the simulation outcome is similar to that of the 
experimental system. Together, these intervals conform the parameter space, all the possible 
combinations of parameter values for a particular model.  
Nowadays, the ODD protocol (Overview, Design concepts and Details) sets the standard for the 
description of IBMs and helps overcome their complexity, making their communication plainer. 
This helps to overcome the historical drawback of not having the necessary protocols for 
communication, resulting in a significant lack of clarity (Railsback 2001; Ferrer et al. 2008; 
Ginovart et al. 2011) 
There are various situations in which IBMs are particularly useful. They allow the creation of 
models with explicit space and can integrate spatial heterogeneity (Ferrer et al. 2008). They are 
useful to study the impact of different elements involved in the model and to verify the validity 
of proposed mechanisms, contributing to the interpretation of data (Grimm 1999, Railsback 
2001, Ferrer et al. 2008). Another interesting use is “simulation as experiment” (Peck 2004), a 
change in paradigm that could complement experimentation in those cultures that are costly, 
difficult or even impossible (Sharma 2005). All in all, IBMs are a good alternative to study 
complex systems (Grimm 1999), when these are formed by autonomous entities (Ferrer et al. 
2008). 
1.4.1. NetLogo 
The platform used in this project for the development of the model is NetLogo 
(http://ccl.northwestern.edu/netlogo/), created in 1999 by Uri Wilensky. It is an open source 
software that is in continuous development at the Center for Connected Learning and 
Computer-Based Modeling of the United States (http://ccl.northwestern.edu/). It is a modelling 
environment specifically designed for the implementation of IBMs and the simulation of 
complex systems with explicit time and space. As a multiagent platform, it is capable of handling 
multiple independent, mobile agents. 
The programming language is simpler than others used for the same purpose and it is much 
more visual and intuitive thanks to automatic animations and graphic controls. However, the 
rate of the simulation is slow compared to other platforms and languages. 
1.4.2. Parasite models 
The existing models related to Leishmaniasis are mostly epidemiological, modelling the 
transmission of the disease. Their main aim is to define control strategies. The main limitation, 
as with all levels of study in the field of NTDs, is the difficulty of parametrisation due to the lack 
of quality of the available data. To date, no in silico models describing the infection process have 
been published. However, there exist infection models of other parasitary illnesses, such as 
malaria and Chagas’ disease. 
There exists an IBM of the infection dynamics of Plasmodium falciparum (the parasite that 
causes malaria) in in vitro erythrocyte cultures developed by Ferrer et al. (2010). This model was 
used in order to define local interactions and integrate the complexity and stochasticity 
necessary to obtain the appropriate emergent behaviours. The model includes interactions 
between agents (erythrocytes and P. falciparum) and between the agents and their 
environment, including transport processes and the culture system. 
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Another model describing processes related to parasitary diseases is a cellular automaton of the 
development of Chagas’ disease after stem cell transplantation, developed by Galvão et al. 
(2009). The model includes the different types of cells in cardiac tissue affected by Chagas’ 
disease. Its aim is to comprehend the contribution of these different cells in chronic chagasic 
cardiomyopathy regeneration by validating behaviour hypotheses. These hypotheses are the 
rules that simulate cellular kinetics in the model. 
1.5. Context and aim 
1.5.1. Trajectory 
This line of research started in 2015 with Núria Pedrós’ bachelor thesis (Pedrós Barnils 2015): 
Analysis and modelling of Trypanosomatidae family in vitro and ex vivo cultures. Here, a 
continuous mathematical model for in vitro cultures was developed, characterising the growth 
of the culture as bi-lineal. 
The development continued in 2016 with Berta Raventós’ bachelor thesis (Raventós Roca 2016), 
where the aim was to improve the quantification methods of the experimental results from 
amastigote in vitro cultures. Different experimental methods were evaluated to assess their 
effects and improve the used methodology. A protocol for the digitalisation of the culture 
preparations was defined. As a result of the collection of images produced, a method for the 
automatization of the interpretation of images has recently been developed: Leishmaniasis 
Parasite Segmentation and Classification using Deep Learning (Górriz et al. 2018). This paper will 
be presented in the X Conference on Articulated Motion and Deformable Objects in Palma, 
Mallorca (Spain) on the 12-13 July 2018. 
In 2017, Berta Raventós developed, in her master thesis, the IBM for in vitro cultures of 
Leishmania infantum that is further studied in this bachelor thesis (Raventós Roca 2017). The 
aim of the model is to describe the behaviour of such cultures and further the understanding of 
them by defining rules for the behaviour of macrophages and parasites. The experimental 
method was also defined in order to obtain results to validate the proposed mechanisms. A first 
approximation to parametrisation was carried out, which this bachelor thesis aims to continue. 
1.5.2. The challenge: parameterising models of complex systems 
Cultures where two or more agents (parasite species, chemical compounds, host cells…) interact 
are complex systems, where it is nearly impossible to evaluate the effect of each element on the 
behaviour of the system. Each agent behaves and interacts in its own way and the behaviour of 
the culture differs with strain and species of parasite, host cell line and medium composition, 
especially when a drug is added. 
As shown in Figure 7, on the one hand, experiments are designed and their results collected and 
analysed. On the other hand, the model is developed based on proposed behaviour mechanisms 
and the parameters are set according to bibliographical data. In order to make the two 
approaches compatible, the experimental design must permit the measure of data that is useful 
for the comparison between experimental results and simulation output. 
Those parameters whose values cannot be found in bibliography must be adjusted. This process 
is known as parametrisation and it involves the comparison of experimental data and simulation 
output with the aim of finding the parameter values that best replicate the experimental system. 
The steps of parametrisation are highlighted in orange in Figure 7. With the results produced, 
the final steps will be carried out and a global analysis will be possible in order to find the 
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combination which best fits the real system. This information will allow, in turn, the optimisation 
of both the experimental design and the IBM. 
1.5.3. Aim and outline 
The aim of this bachelor thesis is to develop a mathematical methodology for the 
parametrisation of the mathematical model describing the behaviour of a Leishmania infantum 
and cell line RAW 264.7 in vitro culture. With this methodology, the model is evaluated and the 
parameter space determined is explored, as highlighted in Figure 7. At the same time, it also 
strives to further understand the characteristic parameters of this particular culture, specifically 
those parameters that are difficult or impossible to measure experimentally. 
A major challenge for the development of a parametrisation method that yields optimum results 
is the definition of strategies for the comparison of experimental and simulated systems. 
Considering the complexity of the real system and the large number of parameters involved in 
describing it, this challenge is by no means trivial. The developed methodology aims to overcome 
this hurdle and be extensible to different strains, species of parasite and host cell lines. 
In Section 2, the experimental protocol for the obtainment of the experimental data used for 
the parametrisation is presented. Next, the model itself is described, followed by the description 
of its parametrisation process. The initial evaluation of the model results in the determining of 
the parameter space, which is subsequently explored. Finally, the results of both these stages 
are presented and discussed. 
 
Figure 7. Flowchart of the steps necessary for the development of an IBM and its corresponding experimental design. 
In orange, the steps carried out in this bachelor thesis. 
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2. Materials and methods 
The following experimental methods were developed and carried out by Raventós Roca (2017). 
All procedures that involve manipulation of cell lines and Leishmania took place in laboratories 
of Security Level II. 
2.1. Leishmania promastigote culture 
The strain used for the assay was L. infantum (WHOM/ES/2016/BCN-877) from the Cryobank of 
Leishmania strains pertaining to the Laboratory of Parasitology of the Facultat de Farmàcia i 
Ciències de l’Alimentació (University of Barcelona). 
The promastigotes were cultivated in Schneider medium (Sigma, ref.: S9895-1L) supplemented 
with 20 % Foetal Bovine Serum (FBS) (AntibodyBcn), 1 % of Gentamicin (Sigma, ref.: G1397-
10ML) and 1 % filtered human urine. The culture was kept in flasks of 25 cm3 (Greiner bio-one; 
ref.: 658175) and maintained at a temperature of 26 ºC. 
2.2. Cell line RAW 264.7 culture 
The cell line used for the assay was the continuous cell line RAW 264.7. It was originally isolated 
from an induced tumour in a mouse by the intraperitoneal4 injection of Abelson’s Murine 
Leukaemia Virus (A-MuLV). The macrophages of this cell line are semi-adherent and find 
themselves in a permanent division process. 
The culture was initiated from a vial of the original culture (106 cells/mL) frozen at - 80 oC in RPMI 
1640 medium (Sigma, ref.: R7388-500ML) and 10% dimethyl sulfoxide (DMSO). In a 25 cm3 flask, 
1 mL of cell culture was deposited, together with 10 mL of RPMI 1640 medium supplemented 
with 10 % FBS and 1 % Penicillin/Streptomycin (P/S) (Sigma, ref.: P4333-20ML). 
The culture was incubated at 37 oC and 5 % CO2 so that the cells would divide forming a 
monolayer. The maintenance of the culture requires the removal of the contents of the flask, 
the adding of fresh medium and the energic scraping of the flasks surface with a Cell Scraper 
(Greiner bio-one, ref.: 541070) in order to separate the cells. This procedure is repeated every 3 
or 4 days. 
2.3. In vitro infection of the cell line with promastigotes 
The in vitro infection of the cell line RAW 264.7 with L. infantum promastigotes took place in 
chambers slides (Thermo ScientificTM NuncTM Lab-TekTM II Chamber SlideTM). This system is made 
up of eight removable polystyrene chambers attached to a glass microscope slide treated to 
ensure a uniform culture surface. The slide (25 x 27 mm) also allows the staining and microscopic 
examination of the culture. Five intervals were studied: 12 h, 24 h, 36 h, 48 h and 72 h. Two 
repetitions (chambers) were prepared for each time interval. 
In each chamber 300 μL of cellular suspension (5·104 cells/ml) were deposited in RPMI 1640 
medium supplemented with 10 % FBS and 1 % P/S. The concentration of the culture was 
determined by an automated cell counting device (TC20TM Automated Cell Counter; BIO-RAD, 
ref.: 145-0101). The cells were incubated for 24 h (37 oC and 5 % CO2) in order to guarantee their 
adherence to the surface of the chamber slide. 
Next, the supernatant was removed and the chambers were washed with RPMI medium (free 
of serum) in order to eliminate any non-adhered cells. Into each of the chambers 300 μL of a 
                                                          
4 The peritoneal cavity is the potential space between the membrane (peritoneum) that surrounds the 
abdominal wall and the membrane that surrounds the internal organs. 
Analysis and parametrisation of an IBM of a Leishmania infantum in vitro culture  22 
 
suspension of stationary phase promastigotes (5·105 promastigotes/mL) were added in 
supplemented RPMI medium. The concentration of promastigotes was determined with a 
haemocytometer. The proportion of macrophages and promastigotes (1:10) and their 
respective concentrations were determined following Bilbao 2014. This ratio corresponds to the 
initial concentration of macrophages and the concentration of promastigotes inoculated. As 
macrophages were incubated for 24 h without inoculum and considering that they are a dividing 
population, it is not the ratio at the time of inoculation. 
The chamber slides were incubated at 35 oC without CO2 for 4 h in order to facilitate the infective 
conditions of the parasite. After this period, they were incubated at 37 oC and 5 % CO2. After 24 
h, the supernatant was removed and the chambers were washed twice with serum free RPMI 
medium in order to eliminate remaining promastigotes. After this, 300 μL of supplemented RPMI 
medium were added and the chamber slides were again incubated at 37 oC and 5 % CO2. 
Once the desired time interval had elapsed, the supernatant was removed and the chamber 
slides were left to dry at room temperature. In the cases of time intervals inferior to 24 h, two 
washes with RPMI medium were done. The slides were fixed with methanol and stained with 10 
% Giemsa colouring during 10 minutes. The set up of the preparations was carried out with the 
set up medium DPX. 
Finally, the number of amastigotes, healthy and infected macrophages were counted from a 
total of 300 cells in an optic microscope. The percentage of infection, the average number of 
amastigotes per infected macrophage and the parasitary index (IP) were calculated. The latter 
is calculated as the product of the other two parameters. 
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3. Description of the model 
The standard description for IBMs is the ODD protocol as described in in Grimm et al. (2006). 
ODD stands for Overview, Design concepts and Details and it is described in detail in Annex A. 
The following is a briefer description of the most relevant aspects of the model. 
3.1. General description 
The aim of the model is to study and describe the in vitro infection of macrophages of the RAW 
264.7 cell line by L. infantum. The dynamics of the community are not preconceived within the 
model but emerge from the interactions between individuals. This concept, emergence, has 
been discussed previously in Subsection 1.4.  
The model considers two types of individuals or agents: macrophages and parasites. 
Macrophages can either be infected or healthy (i.e., not infected) and parasites can either be 
extracellular, adhered to the macrophages’ external membrane or intracellular. Free parasites 
have the ability to move, adhere to macrophages and infect them. Parasites that have 
successfully infected a macrophage can reproduce within them. The individuals are 
characterised by several properties (Table 1), which are determined by a series of parameters 
(Table 2) that can be modified by the modeller. Many of the parameters that describe the 
behaviour of the individuals are difficult to determine experimentally, nor have they been found 
in bibliography. Instead, they have been adjusted by comparing simulation results to 
experimental results. This is known as parametrisation and will be described in detail in Section 
4. 
Table 1. Variables and parameters that characterise the properties of individuals. 
 Name Units Description 
M
ac
ro
ph
ag
e 
diamac µm Diameter of macrophage 
edatmac h Age of macrophage 
imac  Identification index of macrophage 
estatmac  State of macrophage (0: healthy, 1: adhered or 2: infected) 
tinfect h Time the macrophage has been infected 
repromac  Indicates if the macrophage is able to reproduce (1: yes, 0: no) 
rlogisind h-1 R parameter of the logistic growth function of macrophages 
Le
is
hm
an
ia
 
diam µm Diameter of amastigotes 
edatam h Age of amastigotes 
estatam  State of amastigotes (0: free, 1: adhered or 2: intracellular) 
inmac  Index of the macrophage to which adhered and intracellular amastigotes are linked. 
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Table 2. Parameters that govern the behaviour of the individuals. 
 Parameters Units Description Source 
M
ac
ro
ph
ag
es
 
nmacini  Initial number of macrophages 
Experimental 
method 
diamacmax μm Maximum diameter of macrophages Parametrisation 
rlogis h-1 
Parameter R of the logistic function describing 
the growth of macrophages 
Parametrisation 
tdmac h Duplication time of macrophages (Assanga 2013) 
direpromac μm 
Minimum diameter for reproduction of 
macrophages 
Parametrisation 
repart  
Proportion of parasites divided between 
macrophages during duplication 
Parametrisation 
maxinfect  
Maximum number of parasites per infected 
macrophage 
Parametrisation 
Le
ish
m
an
ia
 
namini  Initial number of parasites 
Experimental 
method 
diammax μm Maximum diameter of parasites (Gállego 2001) 
tmortam h 
Time a parasite is able to spend outside, 
without infecting a macrophage 
Parametrisation 
distam μm Distance of movement of parasites Parametrisation 
probenganxa  
Probability of adhesion of a parasite to a 
macrophage 
Parametrisation 
probinfecta  
Probability of an adhered parasite of infecting a 
macrophage 
Parametrisation 
tdam h Duplication time of parasites Parametrisation 
 
L. infantum is considered in promastigote or amastigote form depending on the stage of 
infection. The physiological differences are only taken into account in certain parameters that 
govern their behaviour (time of death, distance of movement), but the model does not consider 
different rules for the two forms. When inoculated, all parasites are in promastigote form. Once 
infection occurs, those parasites that have successfully infected macrophage transform to the 
amastigote form. The washing of the culture (see Section 3) is modelled by removing all free 
parasites (mostly promastigotes) at 24 h. The experimental removal is not complete; therefore, 
it is modelled in a way that most promastigotes are removed, but not with 100 % efficiency. 
The space modelled is equivalent to the optic field of a microscope and consists of a grid of 
400x400 spatial cells. The model runs for 72 time steps and each time step is equivalent to an 
hour. This time limit was chosen because, after 72 h, those cultures without medium renewal 
had a very poor final state. Those with the necessary medium renewal at 72 h showed a 
proliferation of cells that made the quantification of infection difficult and impractical. 
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There are many variables that are not and cannot be accounted for. The inclusion of stochasticity 
at every level is important for obtaining the appropriate emergent behaviours (Ferrer et al. 
2010). This means that all processes are related to a certain probability of occurring and that all 
parameters are subjected to Gaussian noise with a standard deviation of 0.25. 
3.2. Sequence of actions 
In IBMs, actions, each governed by a rule, are executed in sequential order. The flow chart in 
Figure 9 and Figure 9 shows the sequence of actions that will presently be described. The chart 
is especially useful to visualise at what points the state of each individual is evaluated and how 
this state determines the course of actions it must follow. The code of the model can be found 
in Annex B. 
The model, Figure 9, mirrors the experimental method, which means that first healthy 
macrophages are created according to their properties and distributed at random and without 
superposition in the modelled space. The inoculation of the promastigote culture, as described 
in Section 3, is considered as an input in the model. It involves the creation of the parasites 
separately from the macrophages, distributing them randomly in the available space. 
Macrophages, as shown in Figure 9A, increment their age at each time step, which are 
equivalent to one hour. Given they have enough space, macrophages can grow following a 
logistic function depending on their diameter and the available surrounding space. Once they 
have reached sufficient diameter, they can duplicate by bipartition. 
Parasites, as can be seen in Figure 9B, also increment their age with each time step. When they 
change state between extracellular, adhered and intracellular states, as described below, their 
age is set to zero and the count begins anew. The parameter and sequence of behaviour rules 
differ between the three states, so this is first evaluated to decide along which path each 
individual must proceed. 
Extracellular and adhered parasites (those that have been unsuccessful in infecting a 
macrophage) have a certain probability of death related to their maximum age. Adhered 
parasites have double the maximum age with respect to free ones. At time step 24, all 
extracellular parasites die, without considering their age, because of the washing of the culture. 
Extracellular parasites can also move a certain distance in a random direction. The distance of 
movement is reduced to half once 24 hours have passed. This is because all promastigotes have 
been removed and only free amastigotes remain. This difference in distance of movement is a 
way of taking into account the physiological differences between promastigotes and 
amastigotes. 
Free parasites, both promastigotes and amastigotes, have a certain probability of adhering to 
macrophages they encounter and, once adhered, a certain probability of infecting them. Once 
the parasite is intracellular, it can reproduce, given it has attained a certain age, until the 
maximum number of parasites per macrophage is reached. Once this occurs, the macrophage 
burst, returning the parasites to the extracellular state. 
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Figure 8. Flowchart of the macrophage - parasite model implemented in NetLogo. 
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A 
B 
Figure 9. (A) Flowchart of the sequence of actions of macrophages and (B) flowchart for the sequence of actions of 
Leishmania. 
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3.3. Model implementation and simulation scheduling 
The model is implemented in the NetLogo platform, the interface of the simulator is shown in 
Figure 10. The values of the parameters in Table 2 are stored in a commas-separated values 
(CSV) file. Each line of the file contains a parameter combination and has as many lines as 
parameter combinations wish to be tested. 
The simulator reads the file one line at a time, assigning each value to the corresponding variable 
within the model. Because of the stochasticity at individual level, each simulation outcome is 
different, even for the same parameter combination. In order to obtain mean values for the 
output variables, the same combination is repeatedly simulated, as many times as the modeller 
deems appropriate. In this case, 30 repetitions were carried out. 
The output variables are: percentage of infection, percentage of macrophages containing one 
or two amastigotes, percentage of macrophages containing three or four amastigotes and 
percentage of macrophages containing five or more amastigotes. The mean values for all the 
repetitions for these variables at time steps 12, 24, 36, 48 and 72 h are exported in a CSV file. 
Each line is the set of results corresponding to a parameter combination. This data is then 
processed with a different platform, in this case, MATLAB. The processing of data will be further 
described in Section 0. 
 
Figure 10. Interface of the NetLogo simulator (see text for details). 
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4. Analysis and parametrisation 
Most of the parameters governing the behaviour rules of the individuals have not been 
determined experimentally. Therefore, they must be adjusted in a way that the simulated results 
resemble the experimental findings. This is not only a way to obtain a working model, it also 
contributes to shedding light on previously unknown values that are difficult to measure 
experimentally. The overall aim is to find the combination of parameter values that most 
resemble experimental findings and that have values representative of the proposed behaviour 
mechanisms. 
The course of action to be followed, as will be described shortly, is shown in Figure 11. It starts 
with values adjusted in Raventós (2017). The parameters are explored one by one and the 
discrepancy between experimental and simulated results is assessed. An interval where the 
discrepancy is minimum is defined for further exploration. These intervals make up the 
parameter space, the set of all the possible combinations of parameter values contained in the 
model. The parameter space is explored and the result is a distance between experimental 
measurements and simulation outcomes for each parameter combination. One the one hand, 
the combination with the minimum distance value is found (initial optimum values). On the 
other hand, the results of the exploration permit the fitting of an n-dimensional curve to the 
parameter space. In this case, 10 parameters are considered, so the curve would have 10 
dimensions. By studying this curve, an optimum parameter combination can be found. 
In this bachelor thesis no curve has yet been adjusted. The parametrisation process has only 
reached the stage of obtaining the results of the parameter space exploration and finding the 
initial optimum value. 
 
Figure 11. Diagram of the steps of the parametrisation process. 
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4.1. Definition of mathematical distance 
A mathematical distance is defined in Equation (1) as a measure of the discrepancy between 
certain experimental results and the corresponding simulation outcomes.  
𝑑 = ඩ෍൫𝑥௘௫௣,௜ − 𝑥௦௜௠,௜൯
ଶ
௡
௜ୀଵ
 
 
(1) 
 
This distance is used for evaluating the discrepancy between the experimental and simulated 
systems. The variables used are: 
 Infection percentage: the percentage of infected macrophages among the total number 
of macrophages. 
 Percentage of macrophages with 1 or 2 parasites within them. 
 Percentage of macrophages with 3 or 4 parasites within them. 
 Percentage of macrophages with 5 or more parasites within them. 
The distances are evaluated at the time-points when experimental measurements are available 
(12, 24, 36, 48 and 72 hours). The distance that assesses the difference of percentage of infection 
is known as the infection distance (𝑑௜௡௙). The distances that evaluate the discrepancy among 
the number of parasites per macrophage are denoted 𝑑ଵାଶ , 𝑑ଷାସ  and 𝑑ஹହ , respectively. 
Together, these last three distances make up the distribution distance (𝑑ௗ௜௦௧௥), as seen in 
Equation (2). Finally,  𝑑௜௡௙ and 𝑑ௗ௜௦௧௥ are combined to form a global distance (𝑑௚௟௢௕௔௟), as in 
Equation (3). The global distance is used to evaluate the discrepancy between experimental 
results and the simulation output. 
 
𝑑ௗ௜௦௧௥ = ට𝑑ଵାଶଶ + 𝑑ଷାସଶ + 𝑑ஹହଶ   
 
(2) 
 
𝑑௚௟௢௕௔௟ = ට𝑑௜௡௙ଶ + 𝑑ௗ௜௦௧௥ଶ  
 
(3) 
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Different combinations of parameters will be explored, as described in the following sections. 
For each of the considered parameter combinations, 30 simulations are run. As a result, 30 
distances are calculated for each of the five intervals evaluated (12, 24, 36, 48 and 72 hours). In 
total, this accounts for 150 distances. First, the mean distance for the five time-points is 
calculated. The result is a mean infection distance and a mean distribution distance for each 
simulation. With these values, the global distance is calculated for each simulation. Finally, a 
mean for the 30 simulations of each parameter combination is calculated. The final result is a 
single global distance value for each parameter combination. 
The simulations are programmed with NetLogo and the calculation of distances is carried out 
using MATLAB. The process is described in detail in the following sections.  
4.2. Preliminary analysis 
In Raventós (2017), the parameters where adjusted one by one, i.e., by testing a range of values 
for one parameter while keeping the rest constant. Parameters whose values could be found in 
literature or pertained to the experimental method, listed in Table 3, were not tested. The 
parameters that were adjusted are detailed in Table 4. For the preliminary analysis, the code 
used to calculate the mathematical distance from the simulation output and the experimental 
results can be found in Annex C. 
Table 3. Name, description and values of parameters governing the behaviour of macrophages and parasites found 
in literature or determined by experimental method. 
 Parameter Description Value Units Source 
Macrophages 
Nmacini Initial macrophages 100 Individuals Experimental method 
Tdmac Macrophage duplication time 12 h (Assanga 2013) 
Leishmania 
Namini Initial parasites 250 Individuals Experimental method 
Diammax Maximum parasite diameter 3 μm (Gállego 2001) 
 
Table 4. Name, description and values of the parameters governing the behaviour of macrophages and parasites not 
found in bibliography and adjusted in Raventós (2017). 
 Parameters Description Units Original value 
M
ac
ro
ph
ag
es
 
Diamacmax Maximum diameter μm 30 
Rlogis R of logistic function h-1 1.5 
Direpromac Minimum diameter for reproduction μm 60 
Repart Proportion of distribution during macrophage duplication   0.6 
Maxinfect Maximum of parasites per infected macrophage am/mac 6 
Le
ish
m
an
ia
 Tmortam Mortality h 36 
Distam Distance of movement μm 15 
Probenganxa Adhesion probability   1 
Probinfecta Infection probability   0.04 
Tdam Duplication time h 6 
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The next step is to study the parameters in combination. In order to do this, we must define a 
parameter space.  The aim of the preliminary analysis is to explore a series of parameter values 
one by one in order to find an interval where the mathematical distance between experimental 
results and simulation outcomes is minimum as shown in Figure 12. Each of the points is the 
mean value of the mathematical distance of thirty simulations, assessed as described above. 
This is necessary to ensure that an appropriate parameter space is chosen for subsequent study.  
 
Figure 12. Hypothetical result of the preliminary analysis, where each of the point is the mean value of the global 
mathematical distance of thirty simulations. 
The interval is defined by taking a value more or less in the centre of it (central value), as shown 
in Figure 12. Hypothetical result of the preliminary analysis, where each of the point is the mean 
value of the global mathematical distance of thirty simulations., and defining upper and lower 
bounds, as in Equations (4) and (5): 
Upper bound = 1.2 · Central value (4) 
Lower bound =  0.8 · Central value (5) 
 
One must bear in mind that Figure 12 does not represent real data and that it is used merely for 
the purpose of transmitting information. This type of figure will be encountered further along in 
the thesis, when the results of this preliminary analysis are presented in Section 5.2. These 
figures are not used to extract precise results. Their purpose is to have an overview of the 
behaviour of each parameter. With this knowledge, a convenient region of parameter values 
can be chosen for further study. 
 
4.3. Exploration of the parameter space 
In this section, the parametrisation process developed will be described in detail, as shown in 
Figure 13. Parameter combinations from the parameter space defined above will be sampled 
and stored in a CSV file. A series of simulations will be performed with these combinations in 
the NetLogo platform. The results of these will again be stored in a CSV file and later analysed 
with MATLAB. 
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Figure 13. Flow chart of the steps that make up the parametrisation process, with the formats and platforms used 
for each step. 
4.3.1. Latin hypercube sampling 
Because it is not feasible to simulate all the possible combinations, an adequate number of 
samples have to be taken from the parameter space. These have to be taken with care in order 
to get a good representation of the sample space with a limited amount of simulations (Mckay 
et al. 2000). 
The technique used is known as Latin Hypercube Sampling (LHS). It consists of partitioning the 
sample space and ensures that all portions are samples, i.e., that each input variable has all 
portions of its distribution represented by input values (Iman et al. 1981). The LHS was carried 
out with the MATLAB function lhsdesign, as can be seen in the code in Annex D. The intervals 
used are the ones resulting from the Preliminary Analysis and 1000 samples were taken. The 
resulting matrix is stored in CSV format with semicolon separators. 
Each line of the file contained a parameter combination for the 10 parameters described above, 
each combination a sample of the parameter space. Each line contains 11 values. The first an 
identifier for the combination, and its value ranges from 1 to the number of samples taken from 
the parameter space, 1000 in this case. The other ten numbers are the corresponding parameter 
values. 
4.3.2. Incorporation into the model 
Figure 14 shows the flowchart of the code implemented in NetLogo (code in Annex A) in order 
to integrate the proposed parametrisation methodology and the parasite – macrophage IBM. 
Figure 14 shows the overall structure of the code and Figure 15 shows specifically the model. 
Note that there are some structural changes with respect to the flowchart presented in Figure 
9. Figure 9B and 9C remain the same. The differences do not affect the working of the model, 
but the input and output of data. 
The NetLogo CSV extension was used in order to be able to read the file where the parameters 
where stored and import them to the simulator. The input CSV file contains as many parameter 
combinations as samples taken from the parameter space. The first number of the line is the 
identifier, followed by the parameter values. At each run, a line is read and each value assigned 
to its corresponding variable within the model. 
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For each parameter combination 30 simulations were carried out, each with its own setup 
routine, in order to start each simulation afresh. This number of repetitions was chosen in order 
to be able to compute mean values of the output variables considering the stochasticity of the 
model. 
For each combination of parameters, the simulator returns four output variables explained 
above at the five time-points mentioned (12, 24, 36, 48 and 72 h); a total of 20 values. These 
data are stored in another CSV file, where each line contains the simulation outcome of a 
parameter combination, the first number being again the identifier of the combination.  
 
Figure 14. Flowchart of the parametrisation methodology implemented in NetLogo. 
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Figure 15. Flowchart of the parasite - macrophage model modified to fit the parametrisation methodology. 
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4.3.3. Analysis of the results 
The CSV with the outcomes of the simulations are analysed with MATLAB. This analysis consists 
of the evaluation of the resulting distance for each of the individual runs, and then computing 
the mean distance value for each parameter combination. The process is detailed with the code 
and flowchart in Annex E.  
The output is an Excel file that contains, in each line, the identifier of the parameter 
combination, the values of the parameters and the mathematical distance associated to that 
parameter combination. This distance is the result of comparing the experimental results to the 
simulation output of that particular parameter combination. 
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5. Results 
5.1. Experimental results 
Table 5, Figure 16 and Figure 17 show the experimental results obtained from the assays 
performed by Raventós (2017). The analysed variables were the percentage of infected 
macrophages (Figure 16) and the parasite load of these macrophages (Figure 17). 
In Figure 16, the results show an initial increase in the percentage of infected macrophages, 
followed by a decrease because of their lysis. The peak is reached at 36 h. In Figure 17, the 
largest subpopulation is that of macrophages containing 1 or 2 amastigotes. The other two 
subpopulations, macrophages containing 3 or 4 amastigotes and macrophages containing more 
than 5 amastigotes, have similar sizes all along the evolution of the culture. All three 
subpopulations show peaks at 36 h. 
Table 5. Experimental results for percentage of infection, macrophages with 1 or 2 amastigotes, macrophages with 3 
or 4 amastigotes and macrophages with 5 or more amastigotes, at five time-points. 
Time % Infection 1 or 2 amastigotes 
3 or 4 
amastigotes 
5 or more 
amastigotes 
12 22.25 19.5 2.5 0.25 
24 37.17 25 6.5 5.67 
36 50 29 11 10 
48 30.33 21.83 5.67 2.83 
72 18.33 17.67 0.67 0 
 
  
Figure 16. Experimental results of the percentage of infection. 
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Figure 17. Experimental results of the distribution of amastigotes within macrophages. 
To give an idea of the uncertainty of these values, the results for each of the two repetitions, as 
obtained in Raventós 2017, are shown in Figures Figure 18Figure 21. There was only one 
successful repetition for 72 h. The relative position between the points is an indicator of the 
uncertainty of the measurements. Most points show high similitude between repetitions, but 
the measurements at the time point where each curve reaches its peak shows higher 
discrepancy than the rest. 
 
Figure 18. Experimental results of the evolution of 
percentage of infection for two repetitions. There 
was only one successful repetition for 72h. Source: 
Raventós 2017. 
 
Figure 19. Experimental results of the evolution of the 
percentage of macrophages with 1 or 2 amastigotes for 
two repetitions (except 72 h). Source: Raventós 2017. 
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Figure 20. Experimental results for the evolution of the 
percentage of macrophages with 3 or 4 amastigotes 
for two repetitions (except 72 h). Source: Raventós 
2017. 
 
Figure 21. Experimental results for the evolution of the 
percentage of macrophages with 5 or more 
amastigotes for two repetitions (except 72 h). Source: 
Raventós 2017. 
 
5.2. Results of preliminary analysis 
In the following, Figure 22 to Figure 31 collect the results of the preliminary analysis of 
parameters. The horizontal axis represents the range of parameter values and the vertical axis, 
the global mathematical distance between the experimental measurements and the 
corresponding simulation outcomes, as calculated as explained in Section 4.1. The plots help 
visualise which values show a closer correspondence between experimental results and 
simulation results. 
All parameters, except rlogis, present a region in their distribution where the mathematical 
distance between experimental and simulated values is minimal. This indicates that there is a 
region of parameter values that is more suitable for the correct functioning of the model. It also 
indicates that the value of these parameters has an impact on the result of the simulation, i.e., 
that the model is sensitive to them. This is not the case for rlogis, which indicates that its value 
has a negligible impact on the simulation outcome. Note also, that beyond a certain point, the 
value of parasite mortality (tmortam) is no longer transcendent to the outcome of the 
simulation. 
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Figure 22. Result of the preliminary analysis of the parameter 
diamacmax, the maximum diameter of macrophages (μm). 
 
 
Figure 23. Results of the preliminary analysis of the parameter 
rlogis, the r parameter of the logistic function (h-1). 
 
Figure 24. Results of the preliminary analysis of the parameter 
direpromac, the minimum diameter necessary for the duplication 
of macrophages (μm). 
 
 
Figure 25. Results of the preliminary analysis of the parameter 
tmortam, the mortality time for parasites (h). 
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Figure 26. Results of the preliminary analysis of the parameter 
distam, the distance of movement of free parasites (μm). 
 
 
Figure 27. Results of the preliminary analysis of the parameter 
probenganxa, the probability a free parasite of adhering to a 
macrophage. 
 
Figure 28. Results of the preliminary analysis of the parameter 
probinfecta, the probability of an adhered parasite of infecting a 
macrophage 
 
 
 
Figure 29. Results of the preliminary analysis of the parameter 
tdam, the duplication time of amastigotes (h). 
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Table 6. Results of the preliminary analysis of parameters: central value, upper and lower bounds of the interval of 
parameter values where the distance between experimental and simulation results is minimum. 
 Parameters Description Units Lower bound Central value Upper bound 
M
ac
ro
ph
ag
es
 Diamacmax Maximum diameter μm 28.8 36 43.2 
Rlogis R of logistic function h-1 
1.2 
1.5 1.8 
Direpromac Minimum diameter for reproduction μm 
28.8 
36 43.2 
Le
ish
m
an
ia
 
Tmortam Mortality h 41.6 52 62.4 
Distam Distance of movement μm 16 20 24 
Probenganxa Adhesion probability   0.64 0.8 0.96 
Probinfecta Infection probability   0.04 0.05 0.06 
Tdam Duplication time h 8 10 12 
Repart Proportion of distribution during macrophage duplication   0.56 0.7 0.84 
Maxinfect Maximum of parasites per infected macrophage 
am/m
ac 5.6 7 8.4 
 
5.3. Results of exploring the parameter space 
The parameter combination that best adjusts to the experimental results, after the LHS 
exploration of the parameter space, can be found in Table 7. Figure 32 and Figure 33 show 
comparisons of the experimental results and the simulation outcome for this parameter 
combination. The mathematical distance value for this parameter combination is lower than 
that of the initial parametrisation carried out in Raventós (2017); 8.38 and 13.88, respectively . 
This means that, overall, the model fits the experimental system better with this parameter 
combination. 
 
Figure 30. Results of the preliminary analysis of the parameter 
repart, the fraction of amastigotes divided up during the 
duplication of macrophages. 
 
 
Figure 31. Results of the preliminary analysis of the parameter 
maxinfect, the maximum number of amastigotes per 
macrophage. 
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The adjusted values offer a biological interpretation that gives information on the behaviour of 
the individuals. The value of the parameter distam (17.4 µm), the distance the parasite moves 
in the extracellular medium, is relatively small when compared to the diameter of the 
macrophage (30.6 µm), especially considering that the amastigote only moves a distance half 
this value (8.7 µm). The values of probenganxa (0.7) and probinfecta (0.05) show that when a 
parasite comes in contact with a macrophage it almost always adheres successfully 
(approximately 70 % of the time). However, this does not mean that the parasite will be 
successful in infecting the macrophage, which happens around 5 % of the time. 
The most interesting parameter is repart. Its value, 0.64, indicates that when an infected 
macrophage divides by bipartition, 64 % of the parasites within this macrophage go to one of 
the daughter cells and the other 36 %, to the other. On the one hand, questions about the 
structure and working of the parasite vacuole arise: does it split? On the other hand, it could be 
an indication that macrophages are often infected by more than one parasite and, therefore, 
have more than one parasite vacuole, which are distributed into different daughter cells at 
division. 
Table 7. Parameter combination with least discrepancy between experimental results and simulation outcome. 
 Parameter Units Description Adjusted value 
M
ac
ro
ph
ag
es
 
diamacmax μm Maximum diameter of macrophages 30.63 
rlogis h-1 Parameter R of the logistic function describing the growth of macrophages 1.42 
direpromac  Minimum diameter for reproduction of macrophages 37.36 
repart  Proportion of parasites divided between macrophages during duplication 0.64 
maxinfect  Maximum number of parasites per infected macrophage 6.33 
Le
is
hm
an
ia
 
tmortam h Time a parasite is able to spend outside, without infecting a macrophage 44.34 
distam μm Distance of movement of parasites 17.39 
probenganxa  Probability of adhesion of a parasite to a macrophage 0.699 
probinfecta  Probability of an adhered parasite of infecting a macrophage 0.052 
tdam h Duplication time of parasites 8.43 
 
In Figure 32, the experimental results and simulation outcome of the percentage of infection are 
compared. The simulation outcome shows an appropriate behaviour, approximately following 
the shape of the experimental curve. Both curves show a peak at the same time-point, but the 
individual points show some discrepancy. 
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Figure 32. Comparison on the percentage of infection between the experimental results and the simulation outcome. 
Figure 33A shows the distribution of parasites within macrophages for the experimental results  
and Figure 33B, the simulation outcome. The shapes of the curves are similar and so is their 
hierarchy. On the one hand, the simulation curves for percentage of macrophages with 3 or 4 
amastigotes and with 5 or more amastigotes (green and orange) present peaks at the same time-
points as the experimental curves. However, their end value differs noticeably. On the other 
hand, the experimental and simulation curves for the percentage of macrophages with 1 or 2 
amastigotes (blue) present peaks at different time-points. However, their final maximum values 
are similar, as are their final values. 
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Figure 33. (A) Experimental results of the distribution of parasites within macrophages and (B) simulation 
outcome of the distribution of parasites within macrophages. 
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6. Discussion and conclusions 
When studying the behaviour of complex systems such as a parasite – host cell culture is difficult 
to determine how the elements and their interactions contribute to the overall behaviour of the 
system. IBMs are a useful tool for studying complex systems because they focus on individual 
behaviour and interactions. The rules governing the model are those of individual agents, from 
which the macroscopic behaviour of the population then emerges. 
One of the most difficult steps when building IBMs is their parameterization. On the one hand, 
these models usually involve a large number of parameters that must be determined. On the 
other hand, the kind of data needed for univocally determining their values is not always easy 
to be determined experimentally. Therefore, a parameterization process to obtain the best fit is 
always required, and this process must be optimised in order to explore possible combinations 
and select the best solution. 
In this bachelor thesis, a mathematical methodology for the process of parametrisation is 
presented. It optimises the process of parametrisation in terms of results, speed and practicality 
for the user. The criterion used, mathematical distance, can be calculated from any experimental 
results and simulation outcome, independently from the variable measured. This means that 
the methodology is extensible other types of parasite cultures: different strains, species and 
mediums. For example, to assess the effects of drugs by studying the changes in parameter 
values. A qualitative and quantitative interpretation of the effects of potential drugs could give 
information on the mechanism of action of these compounds. It could even be extended to other 
parasite models such as malaria and Chagas’ disease. 
The development of an IBM that simulates L. infantum infection of RAW 264.7 cells sheds light 
on the behaviour of both types of individuals, including the parasites mechanism of action, 
increasing the understanding of this particular culture. It also allows the estimation of 
parameters that are difficult to determine experimentally. For example, the time a parasite can 
survive in the extracellular state is approximately 44 h and the maximum number of parasites a 
macrophage is capable of holding is around 6. 
The model has been developed using the NetLogo simulation platform and its outcome has been 
analysed by means of MATLAB. The two functions, simulation and analysis, could be integrated 
and simulation speed accelerated by using a different programming language, for example C. 
This integration would make the simulations much faster and, especially, would allow the 
storage of much more detailed data in data arrays, which is very complicated in NetLogo. The 
complexity of both the model and the parametrisation process demand a more powerful 
platform in order to be able to increase the accuracy and quality of the results. 
It is important to stress that work such as this is essentially interdisciplinary. Some aspects 
require expertise in parasitology, others, in modelling. The most important aspect, though, is 
the dialogue between the parasitologists and modellers. On the one hand, parasitologists must 
optimise the experiments and measurements in order to facilitate the comparison between the 
model and the experimental system. On the other hand, modellers must integrate the 
experimental results into the model, both in the behaviour rules and in the parameter values. 
Thus, this dialogue allows the further development and optimisation of the experimental design 
and the IBM. 
Returning to Figure 7, which shows the stages in the development of a model and its 
corresponding experimental design, the steps can be retraced. In Raventós (2017), the 
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experimental method was developed and an initial parametrisation of the model was done. In 
this bachelor thesis, the initial evaluation, the determination of the parameter space and the 
exploration of this parameter space were carried out. The next steps include fitting an n-
dimensional function to the parameter space and a global analysis of its outcome. The result of 
this will allow the further development and optimisation of the experimental design and the 
IBM. What is clear is that is first parametrisation is not nearly enough and that the cycle in Figure 
7 needs to be repeated many times in order to reach a satisfactory result. 
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Annex A. ODD protocol for the description of the model 
The standard for description and communication of individual based model, the ODD protocol, 
described in Grimm et al. 2006 is used to describe this model. ODD stands for Overview, Design 
concepts and Details which will be described in detail below. 
1. Overview 
1.1. Purpose 
The aim of the model is to study and describe the in vitro infection of macrophages of the RAW 
264.7 cell line by Leishmania infantum. Adjusting the model to experimental data should help 
shed light on unknown mechanisms of action and on parameters that have not been measured 
or are difficult to determine experimentally. By readjusting the model to experimental data 
acquired from drug screening tests, the mechanisms of action of drugs could be inferred from 
their effects on the values of the model’s parameters. 
1.2. State variables and scales 
The model considers two types of individuals or agents: macrophages and parasites. Each have 
multiple possible states. Macrophages can either be infected or not infected (healthy) and 
parasites can either be extracellular, adhered or intracellular. Parasites have the ability to 
adhere to macrophages and infect them. The state variables describing the elementary 
properties of these individuals are found in Table 1. 
L. infantum is considered in promastigote or amastigote form depending on the stage of 
infection. When inoculated, all parasites are in promastigote form. Once infection occurs, those 
parasites that have successfully infected macrophage transform to the amastigote form. The 
washing of the culture (‘3. Materials and Methods’) is modelled by removing promastigotes at 
24 h. The removal is not complete; therefore, it is modelled in a way that most promastigotes 
are removed, but not with 100 % efficiency. The model does not consider difference in behaviour 
between promastigotes and amastigotes, but it does consider differences in the parameters that 
govern them. 
Table 1. State variables of agents. 
Individual Name Description 
Macrophage 
diamac Diameter of macrophage 
edatmac Age of macrophage 
imac Identification index of macrophage 
estatmac State of macrophage (healthy or infected) 
tinfect Time the macrophage has been infected 
repromac Indicates if the macrophage is able to reproduce (1: yes, 0: no) 
rlogisind R parameter of the logistic growth function of macrophages 
Amastigote 
diam Diameter of amastigotes 
edatam Age of amastigotes 
estatam State of amastigotes (free, adhered or intracellular) 
inmac Index of the macrophage to which adhered and intracellular amastigotes are linked. 
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The space modelled is equivalent to the optic field of a microscope and consists of a grid of 
400x400 spatial cells. The model runs for 72 time steps and each step represents an hour. This 
is the length of the experiments carried out and no experimental data was obtained beyond 72 
hours. In order to attain successful cultures after 72 hours, the culture medium must be 
renewed. This entails a proliferation of cells that makes quantification of infection difficult. If the 
culture is left for more than 72 h without medium renewal, the final state is very poor. 
1.3. Process overview and scheduling 
Time is measured discreetly and at each time step several actions are executed consecutively. 
Both macrophages and amastigotes get older with each time step. Macrophages grow according 
to a logistic function and can reproduce given they have sufficient diameter and surrounding 
space. If the number of parasites inside infected macrophages is larger than the maximum, they 
burst. The information generated by the simulation is collected and stored at each time step. 
Free parasites can move around the space at random. If they come into contact with a 
macrophage, they can adhere to its surface and infect it. Failing to find and infect a macrophage 
entails a probability of death, related to the time spent in the free state. Inside macrophages, 
amastigotes can reproduce once they have reached a given age and will do so until the maximum 
number of amastigotes inside a macrophage is achieved. 
First, actions related to macrophages are executed. The order of actions is: ageing, growth, 
reproduction and bursting. Next, the actions related to Leishmania are executed. The order of 
actions depends on the state of the parasite, so this must first be evaluated. If the state is 
extracellular, those who have exceeded the maximum amount of time in this state die. For those 
that do not die, the order of actions is: movement, adhesion, infection and reproduction. For 
those already intracellular, the only action a part from ageing is reproduction. The sequence of 
these actions is detailed in the model flow chart in Annex 2. 
A significant process of the model, which mirrors the experimental protocol, is the removing of 
all free Leishmania after 24 hours. In the experimental method, all those parasites 
(promastigotes) that have failed to adhere to or infect a macrophage are removed by washing 
the culture, leaving only macrophages and intracellular amastigotes. This is reflected in the 
model by, at time step 24, evaluating which parasites have an extracellular state and by making 
them die, independent of the time they have spent in that state. The experimental process is 
not 100 % efficient and this is also taken into account: the vast majority of promastigotes is 
removed, but some are left behind. 
The model uses periodic border conditions, which are default in the NetLogo platform. For each 
agent that leaves the modelled space, an equal appears on the opposite side of the space. This 
minimizes the effects of finite space and adds realism. 
2. Design concepts 
The dynamics of the community are not preconceived within the model but emerge from the 
interactions between individuals. This concept, emergence, has been discussed previously. The 
interaction between individuals, infection, is direct. There is no individual adaptation. 
Stochasticity is included in the model at every level and it is essential for obtaining the 
appropriate emergent behaviours (Ferrer Savall et al. 2010). Individuals cannot perceive their 
surroundings and make decisions; therefore, their movement is random. There are also 
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probabilities related to death, adhesion and infection. Finally, all parameters of the model are 
subjected to Gaussian noise1 with a value of 0.25. 
L. infantum is considered in promastigote or amastigote form depending on the stage of 
infection. The physiological differences are only taken into account in certain parameters that 
govern their behaviour (time of death, distance of movement), but the model does not consider 
different rules for the two forms. When inoculated, all parasites are in promastigote form. Once 
infection occurs, those parasites that have successfully infected macrophage transform to the 
amastigote form. 
3. Details 
3.1. Initialisation 
The individuals are created according to their properties and are distributed at random and 
without superposition in the area of 400x400 cells. All macrophages are healthy and all parasites 
are extracellular (in promastigote form). 
There are a series of parameters that characterise the individuals and the simulation and that 
can be modified by the modeler. These are summarised in Table 2. Most of these parameters 
have not been determined experimentally nor have they been found in bibliography. Instead, 
they have been adjusted by comparing simulation results to experimental results. 
Table 2. Simulation parameters that can be modified in the interface of the simulator. 
 Parameters Description Source Units 
M
ac
ro
ph
ag
es
 
nmacini Initial number of macrophages Experimental method  
diamacmax Maximum diameter of macrophages Parametrisation μm 
rlogis Parameter R of the logistic function describing the growth of macrophages Parametrisation h
-1 
tdmac Duplication time of macrophages (Assanga 2013) h 
direpromac Minimum diameter for reproduction of macrophages Parametrisation μm 
repart Proportion of parasites divided between macrophages during duplication Parametrisation  
maxinfect Maximum number of parasites per infected macrophage Parametrisation  
Le
ish
m
an
ia
 
namini Initial number of parasites Experimental method  
diammax Maximum diameter of parasites (Gállego 2001) μm 
tmortam Time a parasite is able to spend outside, without infecting a macrophage Parametrisation h 
distam Distance of movement of parasites Parametrisation μm 
probenganxa Probability of adhesion of a parasite to a macrophage Parametrisation  
probinfecta Probability of an adhered parasite of infecting a macrophage Parametrisation  
tdam Duplication time of parasites Parametrisation h 
 
                                                          
1 Gaussian noise is statistical noise having a probability density function equal to that of the normal 
distribution, which is also known as the Gaussian distribution. In other words, the values that the noise 
can take on are Gaussian-distributed. 
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The general subroutine for initialisation is to setup. It clears all variables and sets all global values 
to zero. It also creates the macrophages and distributes them in the space. In the experimental 
design (‘3. Materials and Methods’), macrophages are cultured for 24 h by themselves before 
the promastigote culture is inoculated. The initial number of macrophages in the model is 100 
and the initial number of promastigotes, 250. This is because in 24 h the initial 25 macrophages 
have reproduced twice (their duplication time is 12 h). 
3.2. Inputs 
As described in ‘3. Materials and Methods’, the promastigotes are inoculated after the 
macrophages have been cultured for 24 h. This can be modelled as an input in the form of the 
subroutine to sembra. This subroutine creates the parasites according to their properties. 
Initially, all parasites are extracellular and distributed randomly in the space. 
3.3. Sub-models 
Three kinds of submodels can be distinguished: those related to macrophages, those related to 
Leishmania and those related to the culture system as a whole. 
For macrophages: 
i) Ageing 
Macrophages increment their age at each time step. Their age is measured by the variable 
edatmac, whose units are time steps, each time step equivalent to one hour. 
ii) Growth 
Given they have enough space, macrophages grow according to the logistic function (1). 
𝑑𝐷
𝑑𝑡
=  𝑟 · ൬1 −
𝐷
𝐷௠௔௫
൰ · 𝐷 
 
(1) 
 
In which 𝑟 is the maximum growth rate (rlogis), 𝐷 is the diameter of the macrophage 
(diamac) and 𝐷௠௔௫ is the maximum diameter possible (diamacmax). 
iii) Reproduction 
Given they have enough space, when macrophages reach an age equivalent to the time of 
duplication (tdmac) and they have sufficient diameter (direpromac), they duplicate by 
bipartition. 
For Leishmania: 
i) Ageing 
The parasites increment their age at each time step. When they change state between 
extracellular, adhered and intracellular, their age is set to zero and the count begins anew. 
ii) Death 
Extracellular and adhered parasites (those that have been unsuccessful in infecting a 
macrophage) have a certain probability of death related to their maximum age. This 
maximum age is defined by the parameter tmortam. Adhered parasites have double the 
maximum age with respect to free ones. 
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Because the simulator mirrors the experimental method described in ‘3. Materials and 
Methods’, the culture is washed at 24 h. At all other time steps, the age of free parasites 
(equivalent to the time they have spent in this state) is evaluated and, if the maximum age 
(tmortam) has been reached, those parasites die. At time step 24, however, all extracellular 
parasites, independent of their age, die. 
iii) Movement 
The extracellular parasites can move in a random direction at each time step. The distance 
is determined by distam. The distance of movement is reduced to half once 24 hours have 
passed. 
iv) Adhesion 
Extracellular parasites have a certain probability, probenganxa, of adhering to the surface 
of a macrophage when they encounter one. It is indifferent if the macrophage is infected or 
not. 
v) Infection 
Parasites adhered to a macrophage have a certain probability, probinfecta, of infecting it. 
vi) Reproduction 
When the age of the intracellular parasites reaches the value of the duplication time, tdam, 
they can duplicate by bipartition until the maximum number of parasites per macrophage is 
attained. 
Culture system: 
i) Macrophage lysis 
When the maximum number of parasites per macrophage (maxinfect) is reached, the 
macrophage bursts, returning the parasites to the extracellular state. 
 
  
 
 
 
 
 
 
 
 
 
 
Annex B. Model code implemented in NetLogo 
 
 
 
 
  
Annex B. Model code implemented in NetLogo 1 
 
Annex B. Model code implemented in NetLogo 
The following contains the code implemented in NetLogo that constitutes the described IBM of 
a Leishmania infantum and cell line RAW 264.7 in vitro culture. 
;;;; Model of a Leishmania infantum and cell line RAW 264.7 in vitro culture ;;;; 
 
extensions [csv] 
;; infectable macrophages 
breed [macs mac] 
;; properties: diameter, age, identifier, state (0,1,2), infection (= 0, not infected), time spent infected, 
reproduction index (0 no, 1 yes) 
macs-own [diamac edatmac imac estatmac infect tinfect repromac rlogisind] 
 
;; infectious amastigotes 
breed [ams am] 
;; diameter, age, state, identifier of the cell it is related to (= 0, not related to any cell), age if it is 
infecting, state (0: free, 1: adhered, 2: infecting), to which macrophage it is adhered, which macrophage 
it has infected 
ams-own [diam edatam edatam1 estatam inmac edatami] 
 
;; global variables 
;; time, number of macrophages, number of infected macrophages, number of amastigotes, number of 
adhered amastigotes, number of infecting amastigotes, mean number of amastigotes per macrophage 
globals [temps nmacs nmacsinf nmacs2 nams namsengx namsinf nmacsmorts namsmorts  meanams 
 
;; auxiliary variables 
x0 y0 x1 y1 x2 y2 diam1 compta inc1 mou imac1 para aux1 aux2 distam1 
 
;; parameters contained in the file 
;; line with data, maximum diameter for macs, r of logistic growth function of macs, minimum diameter 
for reproduction of macs, time ams can spend in extracellular state, distance of movement of ams, 
probability of ams of adhering to a mac, probability of infecting mac, reproduction time of ams, 
proportion of ams divided up in mac division, maximum ams per mac 
lhs diamacmax rlogis direpromac tmortam distam probenganxa probinfecta tdam repart maxinfect 
;; number of lines (parameter combinations) contained in the file 
runnum N 
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;; number of repetitions for each parameter combination 
rep rep_go 
 
;; auxiliary variables for the calculation of means for the repetitions for each combination 
aux_inf ; % of infection 
aux_d1 ; 1 i 2 ams per mac 
aux_d2 ; 3 i 4 ams per mac 
aux_d3 ; 5 or more ams per mac 
lectura ; identifier for the parameter combination 
 
;; output variables at time-points (12, 24, 36, 48 and 72 h) 
inf_12 d1_12 d2_12 d3_12 inf_24 d1_24 d2_24 d3_24 inf_36 d1_36 d2_36 d3_36 inf_48 d1_48 d2_48 
d3_48 inf_72 d1_72 d2_72 d3_72 
] 
 
;; Subroutine for the reading of the CSV file containing parameter combinations 
to open-file 
  clear-all 
  file-close-all ; Close any files open from last run 
  file-open "LHS.csv" 
  set runnum 0 
  set rep 30 
  set N 2 
end 
; end of "open file" ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; 
 
;; Main script: reading of the file, assinging of parameter values and simulation 
to read-file 
  set runnum runnum + 1 
  if (lectura >= N) [file-close stop] 
  set lhs (csv:from-row file-read-line ";") 
  show lhs 
  set lectura item 0 lhs 
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  set diamacmax item 1 lhs 
  set rlogis item 2 lhs 
  set direpromac item 3 lhs 
  set tmortam item 4 lhs 
  set distam item 5 lhs 
  set probenganxa item 6 lhs 
  set probinfecta item 7 lhs 
  set tdam item 8 lhs 
  set repart item 9 lhs 
  set maxinfect item 10 lhs 
  set rep_go 0 
  set inf_12 0 
  set d1_12 0 
  set d2_12 0 
  set d3_12 0 
  set inf_24 0 
  set d1_24 0 
  set d2_24 0 
  set d3_24 0 
  set inf_36 0 
  set d1_36 0 
  set d2_36 0 
  set d3_36 0 
  set inf_48 0 
  set d1_48 0 
  set d2_48 0 
  set d3_48 0 
  set inf_72 0 
  set d1_72 0 
  set d2_72 0 
  set d3_72 0 
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while [rep_go < rep] 
  [ 
setup          ;; Initialization of simulation 
go             ;; Simulation 
  ] 
export-files 
end 
; end of main script ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; 
 
;; Subroutine for the initialization of the simulation 
to setup 
  clear-turtles ; it is important to clear all agents from the previous simulation 
  reset-ticks 
  ask patches [set pcolor one-of [119]] 
 
;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; intial cells 
;; all are circles 
  set-default-shape macs "circle" 
  set-default-shape ams "circle" 
;; indexes and globals set to zero 
  set nmacs 0 
  set nams 0 
  set compta 0 
  set nmacsmorts 0 
  set namsmorts 0 
  set temps 0 
  set meanams 0 
  set nmacsinf 0 
  set namsinf 0 
  set aux_inf 0 
  set aux_d1 0 
  set aux_d2 0 
  set aux_d3 0 
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  set rep_go rep_go + 1 
 
;; initial macrophages 
;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; space 
;; The cells occupy their circular space, without overlapping. The counter (contador) indicates how many 
times the simulator tries to allocate a cell in the space before giving up. In this sense, the value of the 
counter conditions how many cells are placed in the space. 
   set compta 0 
   set aux1 1 
   while [(aux1 < nmacini) and (compta < 100000)] 
          ;; positions and diameter are set at random, diamacmax is in CSV and noise is at the interface 
         [set x1 random-float max-pxcor 
          set y1 random-float max-pycor 
          set diam1 diamacmax * (random-normal 1 noise) 
          ;; cells are created so that they do not overlap 
          ifelse all? macs [distancexy x1 y1 > (diam1 + diamac) / 2] 
           [create-macs 1 
            [set xcor x1 
            set ycor y1 
            set heading random 360 
            set diamac diam1 
            set repromac repro 
            set rlogisind rlogis 
            set infect 0 
            set color 117 
            set size diamac 
            set aux1 aux1 + 1 
            set nmacs nmacs + 1 
            set imac nmacs] 
            ] 
          ;; if space is not found, the counter increases 
           [set compta compta + 1] 
          ] 
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;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; initial amastigotes (sembra) 
sembra 
end 
; end of setup ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; 
 
;; Subroutine "sembra", inoculation of amastigotes 
to sembra 
;; diameter of ams is fixed by diammax (interface) and initially all ams are in free state 
;; ams are placed in the space using the same procedure as macs (not overlapping) 
  set diam1 diammax 
  set aux1 0 
  set compta 0 
  while [ (aux1 < namini) and (compta < 10000)] 
  [ set x1 random-float max-pxcor 
   set y1 random-float max-pycor 
   ifelse all? macs [distancexy x1 y1 > (diamac) / 2] 
    [create-ams 1 [ 
      set xcor x1 
      set ycor y1 
      set diam diam1 
      set color 115 
      set size diam1 
      set inmac 0 
      set estatam 0 
      set edatam 0 
      set edatam1 (- tretard) 
      set aux1 aux1 + 1 
      set nams nams + 1]] 
    [set compta compta + 1] 
  ] 
end 
; end of "sembra" ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; 
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;; Simulation 
to go 
while [temps < tmax] 
[ 
set temps temps + dt 
ask macs 
[set imac1 imac 
 set x0 xcor 
 set y0 ycor 
 set edatmac edatmac + dt 
 if (distmac > 0) 
 [ 
  set repromac repro 
  set compta 0 
  set diam1 diamac 
 ] 
 
;;;;;;;;;;;;;;;;; MACROPHAGES 
 set x1 xcor 
 set y1 ycor 
 let diam2 diamac + rlogis * (1 - diamac / diamacmax) * dt 
 if all? other macs [distancexy x1 y1 >= (diam2 + diamac) / 2] [set diamac diam2 set size diamac] 
; reproduction, if age and size are sufficient (with noise) 
  if (edatmac > tdmac * (random-normal 1 noise)) and (diamac > direpromac * (random-normal 1 0.15)) 
and (repromac = 1) 
  [ 
; reproduction if enough space is available 
    set compta 002 
    let diamac0 diamac 
    let diamac1 (diamac / 2 ^ 0.5) * random-normal 1 0.05 
    let diamac2 (diamac ^ 2 - diamac1 ^ 2) ^ 0.5 
    let sumrad (diamac1 + diamac2) / 2 
    set x0 xcor 
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    set y0 ycor 
    set aux1 imac 
    let angle random 360 
    set x1 x0 + sumrad * cos(angle) 
    set y1 y0 + sumrad * sin(angle) 
    while [any? other macs with [distancexy x1 y1 < (diamac1 + diamac) / 2] and compta < 360] [set angle 
angle + 1 
    set compta compta + 1 set x1 x0 + sumrad * cos(angle) set y1 y0 + sumrad * sin(angle)] 
    if compta < 360 
      [ 
       set edatmac 0 
       set diamac diamac1 
       set size diamac 
       set nmacs nmacs + 1 
       hatch 1 
       [set xcor x1 set ycor y1 
        set diamac diamac2 
        set size diamac 
        set imac nmacs 
        set aux2 imac 
        set edatmac 0 
        set repromac repro 
        set infect 0 
        set color 117] 
       ask ams with [inmac = aux1] 
       [ifelse (random-float 1 <= repart) [set heading towardsxy x0 y0 fd (diamac0 - diamac1) / 2] 
       [ set xcor xcor + ( x1 - x0) set ycor ycor + ( y1 - y0 ) set heading towardsxy x1 y1 fd (diamac0 - 
diamac2) / 2 set inmac aux2]] 
       ask macs with [imac = aux1] [ set infect count ams with [(inmac = aux1) and (estatam = 2)]] 
       ask macs with [imac = aux2] [ set infect count ams with [(inmac = aux1) and (estatam = 2)]] 
       ]] 
 ] 
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;;;;;;;;;;;;;;;;; AMASTIGOTES 
;;;;;;;;;;;;;;;;; Actions of amastigotes / State 0: free; State > 0: related to a macrophage 
 
;; WASHING 
if temps = 24 
[ask ams with [estatam = 0][if random-float 1 <= 0.25 [set nams nams - 1 die]]] 
;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; 
    ask ams with [estatam <= 1][set edatam edatam + dt 
;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; adhered ams (estatam = 1) live double: tmortam * (1 + estatam) 
    if (edatam > tmortam * (1 + estatam) * (random-normal 1 noise)) [set namsmorts namsmorts + 1 set 
nams nams - 1 die]] 
;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; those that are infecting 
    ask ams with [estatam = 2] 
     [set edatam1 edatam1 + dt 
      set aux1 inmac 
      if edatam1 > tdam * (random-normal 1 noise) 
      [ask macs with [imac = aux1] [set x1 xcor set y1 ycor set infect infect + 1] 
      set edatam1 0 
      hatch 1 [ 
;; growing towards the centre, more or less 
       set heading (towardsxy x1 y1) 
       let desv1 180 * (random-normal 0 noise) 
       set heading heading + desv1 
       fd (distam / 2) 
       set diam diammax 
       set color black 
       set size diam 
       set estatam 2 
       set edatam 0 
       set edatam1 0 
       set nams nams + 1] 
      ] 
     ] 
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;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; free ams can adhere ;;; 
    ask ams with [estatam = 0][ 
    ifelse temps < 24 [set distam1 distam] [set distam1 0.5 * distam] 
    set x1  xcor +  0.5 * distam1 * (random-normal 0 noise); 
    set y1  ycor +  0.5 * distam1 * (random-normal 0 noise) 
    set xcor x1 
    set ycor y1 
    set inc1 0 
    ask macs 
     [if (distancexy x1 y1 < diamac / 2) and (inc1 = 0) 
      [if random-float 1 <= probenganxa 
        [set inc1 imac 
         set namsengx namsengx + 1 
        ]]] 
    if inc1 > 0 [set color yellow set inmac inc1 set estatam 1] 
    ] 
;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; adhered ams can infect 
     ask ams with [estatam = 1] 
     [if random-float 1 <= probinfecta 
       [set aux1 inmac 
        set estatam 2 
        set color black 
        ask macs with [imac = aux1][set infect infect + 1]]] 
 
; Macrophage BURSTING 
ask macs with [infect > maxinfect * (random-normal 1 noise)] 
 [let iaux1 imac 
  ask ams with [inmac = iaux1] 
   [ set estatam 0 
     set color 115 
     set inmac 0 
     set edatam 0 
     set edatam1 0 
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   ] 
   set nmacs nmacs - 1 
  die 
 ] 
set nmacsinf count macs with [infect > 0] 
set namsinf sum [infect] of macs 
ifelse nmacsinf > 0 [ 
  set meanams namsinf / nmacsinf ] 
[set meanams 0] 
 
; Calculation of output data 
set aux_inf ((count macs with [infect > 0]) / count macs) * 100 
set aux_d1 100 * ((count macs with [infect = 1])+(count macs with [infect = 2]))/ count macs 
set aux_d2 100 * ((count macs with [infect = 3])+(count macs with [infect = 4]))/ count macs 
set aux_d3 100 * (count macs with [infect >= 5]) / count macs 
 
assign 
tick 
] 
end 
; end of Simulation ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; 
 
;; Subroutine to assign output data to output variables 
to assign 
if (temps = 12) 
[ set inf_12 inf_12 + aux_inf 
  set d1_12 d1_12 + aux_d1 
  set d2_12 d2_12 + aux_d2 
  set d3_12 d3_12 + aux_d3 
] 
  
Annex B. Model code implemented in NetLogo 12 
 
if (temps = 24) 
[ set inf_24 inf_24 + aux_inf 
  set d1_24 d1_24 + aux_d1 
  set d2_24 d2_24 + aux_d2 
  set d3_24 d3_24 + aux_d3 
] 
 
if (temps = 36) 
[ set inf_36 inf_36 + aux_inf 
  set d1_36 d1_36 + aux_d1 
  set d2_36 d2_36 + aux_d2 
  set d3_36 d3_36 + aux_d3 
] 
 
if (temps = 48) 
[ set inf_48 inf_48 + aux_inf 
  set d1_48 d1_48 + aux_d1 
  set d2_48 d2_48 + aux_d2 
  set d3_48 d3_48 + aux_d3 
] 
 
if (temps = 72) 
[ set inf_72 inf_72 + aux_inf 
  set d1_72 d1_72 + aux_d1 
  set d2_72 d2_72 + aux_d2 
  set d3_72 d3_72 + aux_d3 
] 
end 
; end of "assign" ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; 
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; Subroutine to write output data to a CSV file 
to export-files 
;; write the information to the file 
let spacer "," 
  set inf_12 inf_12 / rep 
  set inf_24 inf_24 / rep 
  set inf_36 inf_36 / rep 
  set inf_48 inf_48 / rep 
  set inf_72 inf_72 / rep 
  set d1_12 d1_12 / rep 
  set d1_24 d1_24 / rep 
  set d1_36 d1_36 / rep 
  set d1_48 d1_48 / rep 
  set d1_72 d1_72 / rep 
  set d2_12 d2_12 / rep 
  set d2_24 d2_24 / rep 
  set d2_36 d2_36 / rep 
  set d2_48 d2_48 / rep 
  set d2_72 d2_72 / rep 
  set d3_12 d3_12 / rep 
  set d3_24 d3_24 / rep 
  set d3_36 d3_36 / rep 
  set d3_48 d3_48 / rep 
  set d3_72 d3_72 / rep 
 file-open (word "RESULTS1.csv") 
 file-print (list spacer lectura spacer inf_12 spacer inf_24 spacer inf_36 spacer inf_48 spacer inf_72 
                  spacer d1_12 spacer d1_24 spacer d1_36 spacer d1_48 spacer d1_72 
                  spacer d2_12 spacer d2_24 spacer d2_36 spacer d2_48 spacer d2_72 
                  spacer d3_12 spacer d3_24 spacer d3_36 spacer d3_48 spacer d3_72 spacer) 
 file-close 
 file-open "LHS.csv" 
 end 
; end of "export files" ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; 
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Annex C. MATLAB code and flowchart for data analysis 
The following contains a commented code implemented in MATLAB for the analysis of the 
simulation output of the NetLogo model. It imports the results of the model, calculates the 
mathematical distance and returns it as an output value. In particular, this code is used for ‘4.1. 
Preliminary analysis’. Its output is a matrix with each of the five evaluated values of a parameter 
and its corresponding mathematical distance. The flowchart corresponding to this code can be 
found in Figure C-1. 
%% Calculation of mathematical distance to assess the proximity 
between experimental and simulated values 
  
clear all 
close all 
 
% Number of simulations for each parameter set  
Nrep = 30;               
% Output data: %Inf, 1 i 2 am, 3 i 4 am, >= 5 am 
NVariablesOut = 4; 
% Times at which output data is evaluated: 12h, 24h, 36h, 48h, 
60h, 72h       
NTempsAnalisi = 6; 
% Number of input parameters to be studied       
NParametres = 1; 
 
         
%% Importation of simulated data 
% The values of the input parameters are imported from a file 
where all combinations are in order without being repeated 
  
% Import the data 
[~, ~, raw] = xlsread('parametres.xlsx','Hoja1','A2:B2');  
% Path to where the parameters are stored 
  
% Create output variable 
data = reshape([raw{:}],size(raw)); 
  
% Allocate imported array to column variable names 
Run = data(:,1); 
original = data(:,2); 
  
% Clear temporary variables 
clearvars data raw; 
  
NCombinacionsParametres = length(Run); 
Parametres=[original]; 
  
% All experimental data is imported, but only the times 12h, 
24h, 36h, 48h,60h and 72h are chosen 
  
% As many runs as total simulations run  
nRun = Nrep*NCombinacionsParametres; 
% Number of rows in the matrix is the total number of 
simulations              
Nfiles = nRun;                                    
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% Number of columns is the six chosen times for each output 
variable 
Ncolumnes = NVariablesOut*NTempsAnalisi; 
% Matrix to store the results          
Resultats_simulacio = zeros(Nfiles,Ncolumnes);    
% Loop for writing the chosen data to the matrix 
 
iRun = 1; 
    
for i=1:nRun 
     
    % Importation of data 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
    filename = (['RESULTATS_',num2str(iRun),'.csv']); 
    delimiter = ','; 
    startRow = 2; 
     
     
    %% Read columns of data as strings: 
    % For more information, see the TEXTSCAN documentation. 
    formatSpec = '%s%s%s%s%s%s%s%s%s%s%[^\n\r]'; 
  
    %% Open the text file. 
    fileID = fopen(filename,'r'); 
  
    %% Read columns of data according to format string. 
    % This call is based on the structure of the file used to    
generate this 
    % code. If an error occurs for a different file, try 
regenerating the code 
    % from the Import Tool. 
    dataArray = textscan(fileID, formatSpec, 'Delimiter', 
delimiter, 'HeaderLines' ,startRow-1, 'ReturnOnError', false); 
  
    %% Close the text file. 
    fclose(fileID); 
  
    %% Convert the contents of columns containing numeric 
strings to numbers. 
    % Replace non-numeric strings with NaN. 
    raw = repmat({''},length(dataArray{1}),length(dataArray)-1); 
    for col=1:length(dataArray)-1 
        raw(1:length(dataArray{col}),col) = dataArray{col}; 
    end 
    numericData = NaN(size(dataArray{1},1),size(dataArray,2)); 
    for col=[2,3,4,5,6,7,8,9] 
    % Converts strings in the input cell array to numbers. 
Replaced non-numeric 
    % strings with NaN. 
    rawData = dataArray{col}; 
    for row=1:size(rawData, 1); 
        % Create a regular expression to detect and remove non-
numeric prefixes and 
        % suffixes. 
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        regexstr = '(?<prefix>.*?)(?<numbers>([-
]*(\d+[\,]*)+[\.]{0,1}\d*[eEdD]{0,1}[-+]*\d*[i]{0,1})|([-
]*(\d+[\,]*)*[\.]{1,1}\d+[eEdD]{0,1}[-
+]*\d*[i]{0,1}))(?<suffix>.*)'; 
        try 
            result = regexp(rawData{row}, regexstr, 'names'); 
            numbers = result.numbers;       
            % Detected commas in non-thousand locations. 
            invalidThousandsSeparator = false; 
            if any(numbers==','); 
                thousandsRegExp = '^\d+?(\,\d{3})*\.{0,1}\d*$'; 
                if isempty(regexp(numbers, thousandsRegExp, 
'once')); 
                    numbers = NaN; 
                    invalidThousandsSeparator = true; 
                end 
            end 
            % Convert numeric strings to numbers. 
            if ~invalidThousandsSeparator; 
                numbers = textscan(strrep(numbers, ',', ''), 
'%f'); 
                numericData(row, col) = numbers{1}; 
                raw{row, col} = numbers{1}; 
            end 
        catch me 
        end 
     end 
    end 
  
  
    %% Split data into numeric and cell columns. 
    rawNumericColumns = raw(:, [2,3,4,5,6,7,8,9]); 
    rawCellColumns = raw(:, [1,10]); 
  
  
    %% Allocate imported array to column variable names 
  
    Temps = cell2mat(rawNumericColumns(:, 1)); 
    INFECCIO = cell2mat(rawNumericColumns(:, 2)); 
    Unam = cell2mat(rawNumericColumns(:, 3)); 
    Dosam = cell2mat(rawNumericColumns(:, 4)); 
    Tresam = cell2mat(rawNumericColumns(:, 5)); 
    Quatream = cell2mat(rawNumericColumns(:, 6)); 
    Cincam = cell2mat(rawNumericColumns(:, 7)); 
    meanamsmacr = cell2mat(rawNumericColumns(:, 8)); 
     
    %% Clear temporary variables 
    clearvars filename delimiter startRow formatSpec fileID 
dataArray ans raw col numericData rawData row regexstr result 
numbers invalidThousandsSeparator thousandsRegExp me 
rawNumericColumns rawCellColumns; 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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% Transformation of simulator output variables 
 
% Macrophages with 1 or 2 amastigotes      
Unidosam = Unam + Dosam; 
% Macrophages with 3 or 4 amastigotes        
Tresiquatream = Tresam + Quatream;           
% Parasitary index 
IP = INFECCIO.*meanamsmacr;             
      
     Aux1 = 0; 
     Aux2 = 0; 
     Raux = zeros(NVariablesOut,NTempsAnalisi); 
     for j=1:NTempsAnalisi 
        Aux1 = Aux1 + 1; 
        Aux2 = Aux2 + 12; 
     % Time interval selection 
     Raux(1,Aux1) = INFECCIO(Aux2); 
     Raux(2,Aux1) = Unidosam(Aux2); 
     Raux(3,Aux1) = Tresiquatream(Aux2); 
     Raux(4,Aux1) = Cincam(Aux2); 
     Raux(5,Aux1) = meanamsmacr(Aux2); 
     Raux(6,Aux1) = IP(Aux2); 
     end 
      
     % Data is placed in a results matrix (Resultats_simulacio) 
that contains all the data for the mentioned output variables at 
the time intervals 12h, 24h, 36h, 48h, 60h and 72h. 
      
     ColIni = 1; 
     ColFin = ColIni + NTempsAnalisi - 1; 
     Resultats_simulacio(iRun,ColIni:ColFin) = Raux(1,:); 
      
     ColIni = ColFin + 1; 
     ColFin = ColIni + NTempsAnalisi - 1; 
     Resultats_simulacio(iRun,ColIni:ColFin) = Raux(2,:); 
      
     ColIni = ColFin + 1; 
     ColFin = ColIni + NTempsAnalisi - 1; 
     Resultats_simulacio(iRun,ColIni:ColFin) = Raux(3,:); 
      
     ColIni = ColFin + 1; 
     ColFin = ColIni + NTempsAnalisi - 1; 
     Resultats_simulacio(iRun,ColIni:ColFin) = Raux(4,:); 
      
     ColIni = ColFin + 1; 
     ColFin = ColIni + NTempsAnalisi - 1; 
     Resultats_simulacio(iRun,ColIni:ColFin) = Raux(5,:); 
      
     ColIni = ColFin + 1; 
     ColFin = ColIni + NTempsAnalisi - 1; 
     Resultats_simulacio(iRun,ColIni:ColFin) = Raux(6,:); 
      
     iRun = iRun + 1; 
      
end 
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% The time interval 60h is eliminated because no experimental 
data was obtained for this time interval 
  
% Only the output variable %Inf, 1 i 2 am, 3 i 4 am, >= 5 am are 
evaluated, but the model gives us more variables which must be 
removed. 
  
Resultats_simulacio(:,25:36) = []; 
  
Aux3=0; 
Aux4=5; 
Aux5=0; 
  
for i=1:4 
    Aux3=Aux4-Aux5; 
    Resultats_simulacio(:,Aux3)=[]; 
    Aux4=Aux4+6; 
    Aux5=Aux5+1; 
end 
  
%% Importation of experimental data 
  
Resultats_Experimentals = xlsread('ResultatsExperimentals'); 
NTempsAnalisiExp = 5;       % 12h, 24h, 36h, 48h i 72h 
  
%% Calculation of the mathematical distance between experimental 
and simulated values 
  
% Point to point calulation of the mathematical distance between 
the experimental and simulated results 
  
distancia = zeros(nRun,20); 
  
Aux6 = 1; 
  
for k=1:4 % Number of columns of the matrix 
"Resultats_experimentals" 
     
for j=1:NTempsAnalisiExp 
     
for i=1:nRun 
     
    distancia(i,Aux6) = sqrt((Resultats_Experimentals(j,k) - 
Resultats_simulacio(i,Aux6))^2); 
  
end 
  
Aux6 = Aux6 + 1; 
end 
  
end 
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% Distance of infection: related to the output variable %Inf 
  
d_infeccio = distancia(:,1:5); 
  
% Distance of distribution: related to how the amastigotes are 
distributed within the macrophages (1 and 2 ams per mac, 3 and 4 
ambs per mac, more than 5 ams per mac) 
  
d_distribucio = zeros(nRun,NTempsAnalisiExp); 
  
Aux7 = 6; 
Aux8 = 11; 
Aux9 = 16; 
  
for j=1:NTempsAnalisiExp 
     
for i=1:nRun 
     
    d_distribucio(i,j) = sqrt((distancia(i,Aux7))^2 + 
(distancia(i,Aux8))^2 + (distancia(i,Aux9))^2); 
     
end 
  
Aux7 = Aux7 + 1; 
Aux8 = Aux8 + 1; 
Aux9 = Aux9 + 1; 
  
end 
  
% Calculation of the mean for the evaluated times 
  
distancia_mitjana = zeros(nRun,2); 
  
for i=1:nRun 
    distancia_mitjana(i,1) = mean(d_infeccio(i,1:5)); 
    distancia_mitjana(i,2) = mean(d_distribucio(i,1:5)); 
end 
  
% Calculation of the global distance 
  
distancia_global = zeros(Nrep,NCombinacionsParametres); 
  
Aux10 = zeros(nRun,1); 
for i=1:nRun 
    Aux10(i,1) = sqrt((distancia_mitjana(i,1))^2 + 
(distancia_mitjana(i,2))^2); 
end 
  
Aux11 = 1; 
for j=1:NCombinacionsParametres 
for i=1:Nrep 
        distancia_global(i,j) = Aux10(Aux11,1); 
Aux11 = Aux11 + 1; 
end 
end 
 % Calculation of the mean of the global distance 
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distancia_global_mitjana = zeros(1,NCombinacionsParametres); 
  
for i=1:NCombinacionsParametres 
    distancia_global_mitjana(1,i) = 
mean(distancia_global(1:Nrep,i)); 
end 
  
%% Result 
% Calculated distance with the value of the evaluated parameter 
  
Resultat = zeros(2,NCombinacionsParametres); 
  
Resultat(1,:) = Parametres(:,1); 
Resultat(2,:) = distancia_global_mitjana(1,:); 
  
% Results are stored in an xlsx file 
xlswrite('Resultat.xlsx', Resultat)  
 
%% Graphical output 
  
figure(1) 
boxplot(distancia_global(:,1),'Labels',{'Original'}) %Labels to 
be modified according to parameter values 
%ylim([0 60])   % Scale of axes to be adjusted according to 
values of distance 
hold on 
title('Distància global') 
xlabel('Valors paràmetres originals') 
ylabel('Distància') 
hold off 
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 START 
Parameter configuration: 
number of parameters, input 
and output variables and 
time-points 
Importation of simulation results 
Elimination of unnecessary data 
Importation of experimental results 
Calculation of mathematical distance 
Data output: 
spreadsheet and 
boxplot 
END 
Figure C-1. Flowchart illustrating the MATLAB code used for the Preliminary Analysis of the IBM. 
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Annex D. MATLAB code and flowchart for Latin Hypercube 
Sampling 
The following contains the code implemented in MATLAB for Latin Hypercube Sampling (LHS) of 
the parameter space of the model. In this case, the number of dimensions (parameters) is 10 
and the number of samples, 1000. Figure D-1 shows the corresponding flowchart. 
 
%% Parameter space sampling using the latin hypercube sample 
method 
  
%% Import parameter values 
% Import lower and upper boundary values of parameters 
[~, ~, raw] = 
xlsread('Interval_parametres.xlsx','Intervals','B3:K4'); 
  
% Create output variable 
data = reshape([raw{:}],size(raw)); 
  
% Allocate imported array to row variable names 
lb = data(1,:); 
ub = data(2,:); 
  
%% Design of the LHS 
p = 1000;        % Number of points 
N = length(lb);  % Number of dimensions (parameters) 
X = lhsdesign(p,N); 
D = bsxfun(@plus,lb,bsxfun(@times,X,(ub-lb))); 
  
%% Export to an Excel file  
xlswrite('LHS.xlsx',D) 
 
 
START 
Importation of parameter values 
Matrix definition: number of points and number of parameters 
LHS design 
Exportation of LHS matrix 
END 
Figure D-1. Flowchart of the code used to sample the parameter space using the Latin Hypercube Sampling (LHS) 
technique. 
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Annex E. MATLAB code and flowchart for the analysis of the 
parameter space exploration 
The results of the parameter space exploration are analysed using the following code, 
implemented in MATLAB. The mathematical distance is calculated for each parameter 
combination. The output is an Excel file containing, in each line, the identifier of the parameter 
combination, the series of values of the parameters that make up the combination and the 
mathematical distance associated to implementing said combination in the simulator. The 
corresponding flowchart can be seen in Figure E-1. 
%% Script for the analysis of the results from the automatized 
simulations used for parametrisation with the LHS technique 
 
clear all 
close all 
  
%% Parameters 
 
NExpTimes = 5;              % 12h, 24h, 36h, 48h i 72h 
N = 1000;                   % Number of parameter combinations 
NOutput = 4;                % Number of output variables 
(%inf,  1 and 2 ams, 3 and 4 ams,    
more than 5 ams) 
 
 
%% Importation of simulated data 
  
 filename = (['RESULTS1_2605.csv']); 
    delimiter = ','; 
    startRow = 1; 
     
%% Read columns of data as strings: 
    % For more information, see the TEXTSCAN documentation. 
    formatSpec = 
'%s%s%s%s%s%s%s%s%s%s%s%s%s%s%s%s%s%s%s%s%s%s%[^\n\r]'; 
  
    %% Open the text file. 
    fileID = fopen(filename,'r'); 
  
    %% Read columns of data according to format string. 
    % This call is based on the structure of the file used to 
generate this 
    % code. If an error occurs for a different file, try 
regenerating the code 
    % from the Import Tool. 
    dataArray = textscan(fileID, formatSpec, 'Delimiter', 
delimiter,'ReturnOnError', false); 
  
    %% Close the text file. 
    fclose(fileID); 
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%% Convert the contents of columns containing numeric strings to 
numbers. 
    % Replace non-numeric strings with NaN. 
    raw = repmat({''},length(dataArray{1}),length(dataArray)-1); 
    for col=1:length(dataArray)-1 
        raw(1:length(dataArray{col}),col) = dataArray{col}; 
    end 
    numericData = NaN(size(dataArray{1},1),size(dataArray,2)); 
    for 
col=[2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] 
    % Converts strings in the input cell array to numbers. 
Replaced non-numeric 
    % strings with NaN. 
    rawData = dataArray{col}; 
    for row=1:size(rawData, 1); 
        % Create a regular expression to detect and remove non-
numeric prefixes and 
        % suffixes. 
        regexstr = '(?<prefix>.*?)(?<numbers>([-
]*(\d+[\,]*)+[\.]{0,1}\d*[eEdD]{0,1}[-+]*\d*[i]{0,1})|([-
]*(\d+[\,]*)*[\.]{1,1}\d+[eEdD]{0,1}[-
+]*\d*[i]{0,1}))(?<suffix>.*)'; 
        try 
            result = regexp(rawData{row}, regexstr, 'names'); 
            numbers = result.numbers;       
            % Detected commas in non-thousand locations. 
            invalidThousandsSeparator = false; 
            if any(numbers==','); 
                thousandsRegExp = '^\d+?(\,\d{3})*\.{0,1}\d*$'; 
                if isempty(regexp(numbers, thousandsRegExp, 
'once')); 
                    numbers = NaN; 
                    invalidThousandsSeparator = true; 
                end 
            end 
            % Convert numeric strings to numbers. 
            if ~invalidThousandsSeparator; 
                numbers = textscan(strrep(numbers, ',', ''), 
'%f'); 
                numericData(row, col) = numbers{1}; 
                raw{row, col} = numbers{1}; 
            end 
        catch me 
        end 
     end 
    end 
  
    %% Split data into numeric and cell columns. 
    rawNumericColumns = raw(:, 
[3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22]); 
    rawCellColumns = raw(:, [1,10]); 
    rawIndexColumns = raw(:, [2]); 
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%% Convert cells to numeric values 
    Simulation_results = cell2mat(rawNumericColumns(:,:)); 
    Index = cell2mat(rawIndexColumns(:,:)); 
 
  
%% Importation of experimental data 
  
Experimental_results = xlsread('Exp_results'); 
 
  
%% Calculation of mathematical distance 
N_res = length(Experimental_results); 
Distance = zeros(N,N_res); 
  
for i=1:N_res 
    for j=1:N 
        Distance(j,i) = sqrt((Experimental_results(1,i) - 
Simulation_results(j,i))^2); 
    end 
end 
  
% Calculation of the mean value for distance for each outup 
variable 
Mean_distance = zeros(N,NOutput); 
  
for i=1:N 
    Aux1 = 1; 
    Aux2 = NExpTimes; 
    for j=1:NOutput 
        Mean_distance(i,j) = mean(Distance(i,Aux1:Aux2)); 
        Aux1 = Aux1 + NExpTimes; 
        Aux2 = Aux2 + NExpTimes; 
    end 
end 
  
% Calculation of infection and distribution differences 
  
d_inf = zeros(N,1); 
d_dist = zeros(N,1); 
  
d_inf(:,1) = Mean_distance(:,1); 
  
for i=1:N 
    d_dist(i,1) = sqrt((Mean_distance(i,2))^2 + 
(Mean_distance(i,3))^2 + (Mean_distance(i,4))^2); 
end 
  
% Calculation of the global distance 
Global_distance = zeros(N,1); 
  
for i=1:N 
    Global_distance(i,1) = sqrt((d_inf(i,1))^2 + 
(d_dist(i,1))^2); 
end 
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%% Import LHS matrix 
  
Parameter_combinations = xlsread('Comparison'); 
 
  
%% Results 
Results = zeros(N,12);     
% 12 because 1 index, 10 parameter values and 1 distance columns 
 
Results(:,1) = Index(:,1); 
Results(:,2:11) = Parameter_combinations(:,2:11); 
Results(:,12) = Global_distance(:,1); 
  
xlswrite('Results',Results); 
  
 
 
  
 
 START 
Set number of: parameter combinations, time-points 
and simulation output variables 
Importation of simulated data 
Importation of experimental data 
Calculation of mathematical distance 
Importation of LHS matrix (that 
contains parameter values) 
Exportation of results: parameter 
values and mathematical distance 
END 
Figure E-1. Flowchart of the code used to analyse the simulation output of each parameter combination sample used 
in the exploration of the parameter space. 
